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ABSTRACT
THE BIOLOGY OF THE INFLUENZA D VIRUS
JIESHI YU
2020

Influenza D virus (IDV) was first identified in 2011 from clinically ill pigs in America. In
nearly a decade since its discovery, the virus has been detected in multiple animal species
in a vast region of the globe and is considered an important cause of concern to animal
and human health. IDV utilizes cattle as the primary reservoir. The viral infection can
cause mild respiratory disease in cattle and has been indicated as a causative agent of
bovine respiratory disease (BRD) complex that is the most common and costly disease
affecting the cattle industry. Moreover, outbreaks of IDV in swine and bovine are
increasing, and more genetic and serological evidences show that IDV has a potential to
adapt to humans.

IDV is unique among four types of influenza viruses. The thermal and acid stability of
IDV were examined and directly compared with those of influenza A virus (IAV),
influenza B virus (IBV), and influenza C virus (ICV). The results of our experiments
demonstrated that only IDV had a high residual infectivity (~2.5 log units of 50% tissue
culture infective dose ([TCID50]/ml) after a 60-min exposure to 53°C in solution at a
neutral pH, and remarkably, IDV retained this infectivity even after exposure to 53°C for
120 min. Furthermore, the data showed that IDV was extremely resistant to inactivation

xvi

by low pH. After being treated at pH 3.0 for 30 min, IDV lost only approximately 20% of
its original infectiousness, while all other types of influenza viruses were completely
inactivated. Finally, replacement of the hemagglutinin (HA) and neuraminidase (NA)
proteins of a temperature- and acid-sensitive IAV with the hemagglutinin-esterase fusion
(HEF) protein of a stable IDV through a reverse genetic system largely rendered the
recombinant IAVs resistant to high-temperature and low-pH treatments. Together, these
results indicated that the HEF glycoprotein is a primary determinant of the exceptional
temperature and acid tolerance of IDV. Further investigation into the viral entry and
fusion mechanism mediated by the intrinsically stable HEF protein of IDV may offer
novel insights into how the fusion machinery of influenza viruses evolve to achieve acid
and thermal stability, which as a result promotes the potential to transmit across mammal
species.

To better study IDV at the molecular level, a reverse-genetics system (RGS) is urgently
needed, but to date, no RGS had been described for IDV. In this study, we rescued the
recombinant influenza D/swine/Oklahoma/1314/2011 (D/OK) virus by using a
bidirectional seven-plasmid based system and further characterized rescued viruses in
terms of growth kinetics, replication stability, and receptor-binding capacity. Our results
collectively demonstrated that RGS-derived viruses resembled the parental viruses for
these properties, thereby supporting the utility of this RGS to study IDV infection biology.
In addition, we developed an IDV minigenome replication assay and identified the
E697K mutation in PB1 and the L462F mutation in PB2 that directly affected the activity
of the IDV ribonucleoprotein (RNP) complex, resulting in either attenuated or

xvii

replication-incompetent viruses. Finally, by using the minigenome replication assay, we
demonstrated that a single nucleotide polymorphism at position 5 of the 3’ conserved
noncoding region in IDV and influenza C virus (ICV) resulted in the inefficient crossrecognition of the heterotypic promoter by the viral RNP complex. In conclusion, we
successfully developed a minigenome replication assay and a robust reverse-genetics
system that can be used to further study replication, tropism, and pathogenesis of IDV.

Based on the sequences of the hemagglutinin-esterase-fusion (HEF) gene, IDV can be
classified into three genetic lineages: D/OK-lineage, D/660-lineage and D/Japan-lineage.
The D/swine/Oklahoma/1334/2011 (D/OK) and D/Bovine/Oklahoma/660/2013 (D/660)
are the representative strains of the D/OK-, and D/660 -lineages, respectively. We found
that the replication of the D/OK virus was approximately 2 log10TCID50/ml lower than
that of the D660 virus in different cell lines. Interestingly, by using our reverse genetics
system, we generated recombinant chimeric D/OK viruses in that one of each genomic
segments was replaced with the segment from the D660 virus, and observed that only the
replication fitness of the chimeric D/OK virus with the D660 NP segment was
significantly increased. Finally, we identified two positions 247 and 381 within the NP
protein were key determinants of the replication difference between the D/OK and D660
viruses. Interestingly, theses amino acid changes in the NP had no effect on IDV RNP
activity but may affect virus replication in the late stage of the viral life cycles, which
warrants further investigation.
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CHAPTER 1. INTRODUCTION

1.1 Overview of the four types of influenza viruses

1.1.1 Taxonomy and classification

Influenza viruses are enveloped, segmented, single-stranded, negative-sense RNA viruses,
and belong to the Orthomyxoviridae family. Four influenza genera, Alphainfluenzavirus
(Species: Influenza A virus), Betainfluenzavirus (Species: Influenza B virus),
Gammainfluenzavirus (Species: Influenza C virus) and Deltainfluenzavirus (Species:
Influenza D virus) (1), are classified on the basis of antigenic differences in the
nucleocapsid protein (NP) and matrix protein (M). Influenza A virus (IAV) can be further
divided into subtypes based on the haemagglutinin (HA) and neuraminidase (NA)
glycoproteins. To date, 18 different HA subtypes (H1-H18) and 11 different NA subtypes
(N1-N11) have been identified in IAV. Three subtypes of IAV, H1N1, H2N2 (circulated
from 1957 to 1968) and H3N2, have been found circulated in humans (2). Influenza B
virus (IBV), according to the major surface HA antigen, can be broken down into two
lineages (B/Yamagata and B/Victoria) (1). Influenza C virus (ICV) has six evolutionary
lineages represented by Taylor/47, Kanagawa/1/76, Yamagata/26/81, Aichi/1/81, Sao
Paulo/378/82, and Mississippi/80 (3). Influenza D virus (IDV) was first isolated in 2011
(4) and officially named in 2016 (https://www.cdc.gov/flu/about/viruses/types.htm). IDV
can be genetically classified into three lineages: D/OK-, D/660-, and D/Japan-lineages,
based on the hemagglutinin-esterase-fusion (HEF) gene (5).
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1.1.2 Genomes and viral particles of influenza A, B, C, and D viruses

The influenza A and B virus genomes each consist of eight segments, while influenza C
and D virus genomes each contain seven segments (Figure. 1-1). The three longest
segments of influenza viruses encode the polymerase subunits PB2, PB1 and PA/P3,
respectively. In some IAV strains, the PB1 segment can also produce a small accessory
protein (PB1-F2) in a +1 alternative reading frame, which can induce apoptosis and play
a role in killing host immune cells (6). The fourth longest segment of ICV/IDV codes for
the only one surface glycoprotein HEF, while IAV and IBV contain two segments (the
fourth and sixth segments) encoding two surface glycoproteins HA and NA, respectively
(Figure 1-1). The sixth longest segment of IBV (NA) can also encodes the NB matrix
protein in a -1 alternate reading frame (7). The fifth longest segment of influenza viruses
encodes nucleoprotein (NP). The last shortest two segments (M and NS segments) each
produce two proteins, M1 and M2 from the M segment, and NS1 and NS2 from the NS
segment, respectively, by different expression strategies.

Influenza viruses are enveloped particles with a diameter of 80 to 120 nm. IAV and IBV
have two major surface glycoproteins (HA and NA) embedded in the envelope, forming
the outer spikes of the virus particle (Figure 1-1). HA recognizes the cellular receptor and
fuses the viral membrane to the cellular membrane for the entry, while NA removes the
receptor from the cell surface and plays a role in virus release. ICV and IDV have only
one spike protein (HEF) in the viral membrane (Figure 1-1). Three functions are
combined in HEF protein: receptor binding, membrane fusion and esterase activity as
compared to the functions in both HA and NA proteins of IAV and IBV (8). In addition
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to spike proteins, M2 protein is also embedded into the viral membrane (Figure 1-1),
which acts as an ion channel (9, 10). M1 protein, serving as a matrix protein, is attached
to the inner leaflet of the lipid bilayer (Figure 1-1) (10). Inside the enveloped virion, the
viral genome segments are coated by the nucleoprotein (NP). NP together with the RNA
polymerase components (PB2, PB1, and PA/P3) form the viral ribonucleoprotein
complexes (vRNPs) (Figure 1-1) that are essential for transcribing all virally encoded
mRNAs and for replicating all viral genome RNA (vRNA) segments. Each vRNA
segment exists in the form of a vRNP. It is known that IAV and IBV package eight
vRNPs arranged in a “1+7” pattern into their virions (11, 12). Interestingly, ICV and IDV
also package eight vRNPs arranged in the “1+7” pattern though they only have seven
genome segments (13). It is still unclear what is the mysterious eighth vRNP observed in
the virions of ICV and IDV.

Figure 1-1, Schematic presentation of IAV/IBV and ICV/IDV. Influenza A and B virus particles
possess 8 genomic segments (left), while influenza C and D virus particles contain 7 genomic
segments (right). The envelope and membrane proteins HEF (ICV/IDV), HA and NA (IAV/IBV),
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and M2 overlay the M1 matrix, which enfolds the virion core. Each vRNA segment forms an
RNP together with the NP and RNA polymerase proteins (PB2, PB1, and PA/P3).

1.1.3 General characteristics of the four types of influenza viruses

Among the four types of influenza viruses (Table 1-1), IAV is the most common and the
most pathogenic, causing seasonal epidemics every year and on some occasions,
worldwide pandemics. IAV infects a wide variety of hosts including humans, birds,
horses, pigs, dogs and marine mammals (2, 14). Waterfowl are the major reservoir of
IAV and the amplification host harboring all different subtypes of viruses with the
potential reassortment, producing new antigenic variants to which humans do not have
pre-existing immunity (15). Bird-origin influenza viruses can cross the species barrier
and infect humans to cause pandemics. There were three recorded pandemics in the last
century, including the 1918 H1N1 Spanish pandemic, the 1957 H2N2 Asian pandemic,
and the 1968 Hong Kong pandemic (16). In 2009, a novel swine-origin H1N1 influenza
virus emerged to cause the first human influenza pandemic of the 21st century (2). In
addition, various other influenza A viruses of pig- and bird-origin, such as H5, H6, H7,
H9, and H10, also have the capacity to infect and spread among humans and, in some
cases, result in severe disease and death (2, 16). IBV, like IAV, can cause seasonal
epidemics in humans but lacks the ability to trigger influenza pandemic. Approximately
25% of the influenza cases are caused by IBV infection, and sometimes IBV can
dominate influenza seasons like the 2017-2018 seasonal influenza in Europe (17). IBV
utilizes human as the primary reservoir (18). Although there were cases of IBV crossing
over from humans to other species, such as the IBV outbreak in seals in The Netherlands
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in 1999, IBV is largely restricted to circulate in humans (18). ICV is not thought to cause
epidemics and only cause mild clinical symptoms in humans (19). The main reservoir of
ICV is humans, but it also infects pigs, dogs, and bovines (20). IDV uses cattle as the
primary reservoir and can be transmitted from cattle to swine (4, 21, 22). Antibodies
specific for IDV were detected in horses, small ruminants, wild boars, camels, and
humans especially with cattle exposure (23-26), indicating that IDV may have a wide
host range and can spread from cattle to humans or other animal species.

Table 1-1. General characteristics of the four types of influenza viruses
IAV

IBV

ICV

IDV

Severity of illness

++++

++

+

+

Reservoir

Waterfowl

Human

Human

Bovine

Human epidemics

Yes

Yes

No

No

Human pandemics

Yes

No

No

No

Animal hosts

Birds, horses, pigs, Seals

Pigs

dogs, and marine

dogs

and Pigs,

mammals

cattle,

goats,

sheep,

horses

and

camels
Antigenic changes

Shift and drift

Drift only

Drift only

Drift only

Genome

8 segments

8 segments

7

7 segments

segments
Glycoproteins

HA, NA

HA, NA

Receptors

α-2,3 or α-2, 6-linked sialic acids

HEF

HEF

Neu5,9Ac2 Neu5Gc9Ac and
Neu5,9Ac2

Viral attachment to receptors on the host cell surface is the initial step of the virus life
cycle. Sialic acid (SA) has been found to serve as a receptor of many important human
and animal pathogens, including influenza, parainfluenza, corona, noro, rota, mumps, and
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DNA tumor viruses (8). SA is the member of the large family molecules derived from
neuraminic acid, which is a monosaccharide containing a nine-carbon backbone,
ubiquitously expressed in higher vertebrates (27, 28). N-acetylneuraminic acid (Neu5Ac)
and N-glycolylneuraminic acid (Neu5Gc) are the most common SAs found on
mammalian cell surfaces, both of which are ligands for influenza viruses. SAs are
generally attached to glycan chains of glycoproteins or glycolipids via different
glycosidic linkages. The most frequent linkage types are α2,3-linkage and α2,6-linkage to
a galactose residue. IAV and IBV only recognize α2,3- or α2,6-linked sialic acid moieties
as receptors (8) (Table 1-1). However, ICV utilizes N-acetyl-9-O-acetylneuraminic acid
(Neu5,9Ac2) (Table 1-1) that has an additional O-acetyl group at C9 position as the
receptor, which is independent of α2,3- or α2,6-linkage to the following galactosyl
residue

(20).

IDV surface

glycoprotein

HEF

can

bind

both

N-acetyl-9-O-

acetylneuraminic acid (Neu5,9Ac2) and 9-O-acetylated N-glycolylneuraminic acid
(Neu5Gc9Ac) (Table 1-1) regardless the α2,3- or α2,6-linkage, which indicates IDV uses
these 9-O-Ac-SAs as its receptor for entry into the cell (29, 30). Almost all viruses attach
to the cell membrane via their surface proteins binding to the specific receptors on the
host cells. The specificity and affinity of the interaction between influenza virus surface
glycoproteins and SA receptors contribute to the viral tissue tropism, host range,
pathogenesis, and transmission.

It is generally accepted that avian influenza A viruses preferentially bind to α2,3-linked
SAs and replicate in the gastrointestinal tract of the host, while human influenza A
viruses have a higher affinity for α2,6-linked SAs that are expressed in the upper
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respiratory tract of humans (2, 31). Pigs have been shown to express high levels of both
α2,3- and α2,6-linked SAs in their respiratory epithelial cells, possibly serving as a
mixing vessel that allow for binding of both avian and human influenza viruses (2, 32).
IBV has a relatively low receptor-binding affinity compared with IAV (18, 33). However,
more studies are needed to know if the receptor-binding specificity and affinity determine
the pathogenicity and restricted host range of IBV. Structure studies show that IDV HEF
has an open channel in the receptor-binding pocket (RBP), while in the structurally
identical site of ICV HEF, there is a salt bridge (29). It has been suggested that the more
open receptor binding cavity of IDV HEF contributes to the broader receptor binding and
broad tissue tropism of IDV when compared to that of ICV (22, 29, 30).

Following attachment, the influenza virus is endocytosed and traffics to the acidic
endosomes. The acidic condition facilitates a conformational change in the HA/HEF,
exposing the fusion peptide that mediates the fusion of the viral envelop with the
endosomal membrane (34). At some point, the lower pH activates the M2 ion channel,
which as a result, pumps the hydrogen ions from the endosome into the virus particle (35).
Further acidification of the viral interior causes the disruption of the M1 lattice, which
enables the release of the viral RNPs into the host cytoplasm (34, 36). After released
from the virion, RNPs are transported to the cellular nucleus where all influenza virus
RNAs are synthesized. Using the negative-sense vRNA as a template, viral mRNA and
complementary RNA (cRNA) are produced. The mRNA is then used for viral protein
synthesis in the cytoplasm, and the cRNA templates are used subsequently for generation
of more vRNA copies in the nucleus (34). The newly synthesized vRNA copies, viral
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polymerase (PB2, PB1, PA/P3) and NP are assembled into the new vRNPs. Once
assembled, the new vRNPs are then exported from the nucleus with the help provided by
NS2 protein (NEP) and eventually destined to the lipid raft domain of the plasma
membrane for packaging into assembled and budding progeny influenza virions (37).
Until now, it remains unclear how influenza virus packages all its different vRNPs into a
progeny virion. Following budding driven by concerted action of HA/HEF and M2
proteins from the cell surface of an infected cell, the influenza virus spike proteins
continue to bind to the SAs embedded on the plasma membrane. Influenza virus release
to extracellular space is dependent on the sialidase activity of NA in IAV and IBV, or the
esterase activity of HEF in ICV and IDV (20, 37). To release freshly budded viral
particles from the host cells, the NA performs receptor destroying activity to cleave the
terminal sialic acid residue from cell-surface glycoproteins and gangliosides, while the
HEF utilizes its esterase activity to remove the acetyl group from position C9 of
Neu5,9Ac2 (20). From primary virus attachment to progeny virus release, all influenza
viruses share similar steps in their replication cycles, but different types of the viruses
behave diversely in each step of the life cycles. In this review, I summarize recent
advance in influenza D virus research and discuss how novel knowledge we have learned
from IDV discriminate it from other types of influenza viruses.
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1.2 The biology of the influenza D virus

Since the initial isolation in America in 2011 through the present, influenza D virus (IDV)
has emerged as an important concern to animal and human health worldwide. IDV has
the exceptional thermal and acid stability, a broad host range and an extensively global
distribution. It has been found to utilize cattle as the natural reservoir and amplification
host with periodical spillover to other mammalian species. IDV infection can cause mild
respiratory illness in cattle and has been implicated as a contributor to bovine respiratory
disease (BRD) complex that is the most common and costly disease affecting the cattle
industry. On the other hand, outbreaks of IDV in swine and bovine herds have continued
to increase, and more evidences suggest that IDV poses a potential risk to humans. In this
review, I summarize the epidemiology of IDV followed by discussion of its pathogenicity,
zoonotic potential, and unique properties of this novel virus.

1.2.1 Epidemiology of IDV worldwide

1.2.1.1 IDV in North America

In April 2011, a viral isolate with approximately 50% amino acid identity to the human
ICV was identified from a clinically-ill pig with influenza-like symptoms in Oklahoma,
USA (4). It was initially thought to be a new subtype of ICV that circulated in pigs.
However, further characterization suggested that the virus was genetically, antigenically
and biologically distinct from the human ICV (21). This novel virus used a new
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mechanism to produce the M1 protein and was unable to productively reassort with the
human ICV in cell culture (21). Antigenically, no cross-reactivity was detected between
antibodies against this new virus and the human ICV in the hemagglutination inhibition
(HI) assay (21). According to these differences to the human ICV, the International
Committee on Taxonomy of Viruses (ICTV) classified this virus as a new genus
(Deltainfluenzavirus, Species: Influenza D virus) of the family Orthomyxoviridae.

Although the first IDV was isolated from a diseased pig, subsequent follow-up studies
demonstrated that IDV widely spread in cattle (21, 38). Agricultural cattle has not been
considered to be susceptible to influenza viruses until the discovery of IDV (39). Initial
epidemiological investigation of IDV in pigs showed low seropositive rate (9.5%, n=220)
(4) (Table 1-2). In addition, the percentage of IDV positivity was less than 0.1% by RTPCR during the routing testing of nasal swabs from pigs, and the isolation of IDV from
pigs was also infrequent (21). However, higher positive rate (18%, n=48) of IDV was
found in a diagnostic testing of nasal swabs from cattle with respiratory disease by RTPCR (Table 1-2), and viruses were successfully isolated from the 5 of 8 positive samples
(21). Another surveillance study from the same group found that 10 of the 208 clinical
samples (4.8%) submitted for laboratory diagnosis of BRD complex were tested positive
for IDV by RT-PCR (Table 1-2), and 6 viruses were isolated from the 10 IDV positive
samples (38). Moreover, two studies in young calves reported that neonatal cattle showed
high levels of maternal antibodies against IDV, 94% and 98% respectively (40, 41).
These two studies also suggested that IDV has been present in the US cattle herds
(Mississippi and Nebraska) since as early as 2003 (40, 41). A nationwide serosurveillance
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of IDV in the United States found an overall 77.5% (n=1992) seropositivity rate in cattle
serum samples collected across the country in 2014-1015 (Table 1-2), but the prevalence
rates varied from 47.7% to 84.6% among different regions (42). Furthermore,
seropositive samples were found in 41 of the 42 US states, indicating a widely circulation
of IDV in the US cattle population during 2014-2015 (42). Two studies, by metagenomic
sequencing of samples collected from feedlot cattle in America, Canada, and Mexico,
indicated that IDV was detected and significantly associated with BRD (43, 44). The
widespread presence of IDV and relative ease of the virus isolation in cattle suggested
that cattle represent the primary reservoir for this novel influenza virus (21).

Interestingly, further surveillance of IDV in North America revealed that multiple
nonbovine animal species were susceptible to IDV. A serological survey that was
performed to determine if small ruminants (sheep and goats) and poultry (chicken and
turkey) were potential hosts to IDV showed that 5.2% (n=557) of sheep serum samples
and 8.8% (n=91) goat serum samples were positive for IDV antibodies, while all tested
poultry serum samples, collected from the midwest US, were negative for IDV antibodies
(23) (Table 1-2). In contrast to poultry data reported in this study, a most recent
molecular diagnosis study revealed the presence of IDV genomes in poultry farms of
Southeast Asia (45). Equine was also added into a growing host range of IDV based on a
serological surveillance of equine populations through the US. This study showed that an
overall 15.7% (n=364) of equine serum samples were positive for antibodies against IDV
(24) (Table 1-2). In America, feral swine are considered as important vectors for IAV
transmission between domestic and wild animals (46, 47). The seroprevalence
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investigation of IDV in feral swine showed that 57 of 256 (19.1%) samples were IDV
seropositive (Table 1-2), which implied that feral swine might play a role in the ecology
of IDV (48).

Based on the phylogenetic analysis of the nucleotide sequence of the HEF gene, IDV
strains circulating in North America belonged to two distinct genetic lineages represented
by D/swine/Oklahoma/1334/2011 (D/OK) and D/bovine/Oklahoma/660/2013 (D/660)
(38) (Figure 1-2). These two lineages currently co-circulate in U.S. cattle populations and
frequent reassortments between these two lineages in animals lead to generation of new
antigenic variants, which can break through the pre-existing herd immunity and pose a
further threat to agricultural animal health.

1.2.1.2 IDV in Europe

The presence of IDV in Europe was first reported in France in 2015, with detection of 6
(4.5%) IDV-positive samples from 134 tested cattle samples during 2011-2014 (49)
(Table 1-2). Following that report, IDV was found to widely spread throughout other
European countries including Italy, Luxembourg, Ireland and United Kingdom (50-53)
(Table 1-2). The prevalence of IDV in Europe was similar to that in North America, in
which the virus and/or its specific antibodies were detected in multiple animal species
including cattle, swine, wild boars, sheep and goats, while the highest prevalence of IDV
was observed in cattle (52, 54-57) (Table 1-2). The serosurveys in Italy, Luxembourg and
Ireland revealed the extremely high IDV-seropositive rates in cattle (92.4%, 80.2% and
94.6%, respectively) (52, 55, 57) (Table 1-2). In France, IDV was identified from cattle
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during 2011-2014, and a recent country-level study showed a high seroprevalence of 47.2%
(n=3362) in cattle between 2014 and 2018, which indicated that once IDV was
introduced, it might spread efficiently in cattle throughout the country (49, 56) (Table 12). Compared to the prevalence of IDV in cattle, the seropositivity rate in pigs is lower
(Table 1-2), implying that the virus was not widespread but commonly circulated in pigs.
To better understand the epidemiology and importance of IDV in the Italian swine
population, serological tests were performed on 3698 swine serum samples collected in
2009 and 2015 from the same region. The results showed that in 502 sera collected in
2009, only 3 samples were positive to IDV, while 364 (11.7%) positive samples were
detected from a total of 3106 swine sera collected in 2015, suggesting the prevalence of
IDV in pigs were steadily increasing over the past several years in Italy (58).

Phylogenetic analysis showed that most European IDV strains belonged to the D/OK
genetic lineage (Figure 1-2). Unexpectedly, an Italian group recently described the first
identification of the D/660 genetic lineage in Europe (59). Analyses of the full-genome
sequences demonstrated the co-circulation in Italy of the two distinct IDV lineages (59).
Moreover, a novel reassortant virus was detected in a dairy farm, with the PB2, PB1, NP,
P42 and HEF segments from the D/660 genetic lineage and the P3 and NS segments from
the D/OK genetic lineage (59). These findings highlight the need to continue monitoring
the prevalence of IDV in Europe in order to better understand its epidemiology and
evolution.
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Figure 1-2, Phylogenetic tree for the HEF segment of IDV. Maximum-likelihood analysis in
combination with 1000 bootstrap replicates was used to derive tree based on the nucleotide
sequences of the HEF. More than 50% of the bootstrap values are shown next to the branches.
The scale bars indicate the number of substitutions per site. Red: IDV in North America; Purple:
IDV in Asia; Green: IDV in Europe.
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Table 1-2. The epidemiology of IDV worldwide
Country (Ref.)

Time

Species

Method

Positive rate: Symptom-Health-Overall

America (4)

2007-2009
2011
2013
2014
2001-2007,
2014
2012-2013
2013-2014
2004-2006
2014
2014-2015
2015
2003-2004
2016
-2011-2014
2009-2016
2012-2018

Human
Swine
Cattle
Cattle
Sheep
Goat
Feral swine
Neonatal calves
Cow-calf herds
Weaned calves
Cattle
Equine
Cattle
Exhibition swine
Human
Cattle
Wild boars
Swine
Cattle
Ovine
Caprine
Swine
Cattle
Human
Swine
Swine
Cattle
Cattle
Cattle
Cattle
Swine
Swine
Cattle
Cattle
Swine
Ovine
Cattle
Cattle
Cattle
Swine
Goat
Cattle
Cattle
Cattle
Cattle
Camel
Cattle
Small ruminants
Cattle
Cattle
Cattle
Small ruminants
Camel

HI
HI
RT-PCR
RT-PCR
HI
HI
HI
HI
HI
RT-PCR
HI
HI
HI
RT-PCR
HI
RT-PCR
HI
HI
HI
HI
HI
RT-PCR
RT-PCR
HI
RT-PCR
HI
RT-PCR
RT-PCR
HI
HI
HI
RT-PCR
RT-PCR

---4.8% (n=208)
-----23.6% (n=55)
-----------0.7% (n=150)
1.3% (n=150)
-2.5% (n=845) #
-10.6% (n=936) #
5.4% (n=895)
----5.6% (n=320)
64.9% (n=1183)
--8.7% (n=104)
-9.7% (n=404) #
31.3% (n=64) #
31.8% (n=88) #
-1.7% (n=172)
-4.0% (n=76)
---------

America (21)
America (38)
America (23)
America (48)
America (40)
America (42)
America (24)
America (41)
America (60)
America (25)
France (49)
France (54)
France (56)

2014-2018

Italy (50)

2014-2015

Italy (61)

2005-2017
2015-2016
2009,2015
2018-2019
2014-2016
-2012-2016
2014-2015
2014-2015
2014-2016
2016-2017

Italy (58)
Italy (59)
Italy (55)
Luxembourg (52)
Ireland (53)
Ireland (57)

--

United Kingdom (51)
China (62)

2017-2018
2014

China (63)

2016

Japan (64)
Japan (65)
Japan (66)
Turkey (67)
Ethiopia (68)

2016
2016-2017
2010-2016
2018-2019
--

Togo (69)

2017-2019

Morocco (26)
Togo (26)
Benin (26)
Togo (26)
Kenya (26)

2012-2015
2009,2015
2012,2014
2013
2015

HI
RT-PCR
RT-PCR
RT-PCR
HI
RT-PCR
HI
RT-PCR
HI
HI
HI
HI
HI
HI
HI

-------94.0% (n=448)
13.5%-18.3%
2.4% (n=82)
-----------------1.1% (n=895)
-80.2% (n=450)
-0.7% (n=427)
-94.6% (n=1219)
---0.66% (n=453)
1.0% (n=100) #
2.0% (n=50)
0.0% (n=50)
28.6% (n=28)
2.4% (n=205)
13.5%-50.0%
----------

1.3% (n=316)
9.5% (n=220)
18.0% (n=48)
-5.2% (n=557)
8.8% (n=91)
19.1% (n=256)
-15.9% (n=605) #
-77.5% (n=1992)
15.7% (n=364) #
81.9% (n=293)
0.07% (n=2862)
97.0% (n=35)
4.5% (n=134)
0.5% (n=644)
1.6% (n=2372)
42.7% (n=3326)
1.5% (n=1430)
3.2% (n=625)
--26.2% (n=1281)
-10.6% (n=3698) #
-6.5% (n=895)
92.4% (n=420)
-5.9% (n=287)
---5.8% (n=377)
4.8% (n=288)
--7.9% (n=504) #
18.4% (n=114) #
20.3% (n=138) #
-2.1% (n=377)
30.5% (n=1267)
-57.9% (n=38) #
4.5% (n=399)
3.8% (n=737)
35% (n=200)
10.4% (n=201)
1.9% (n=207)
1.8% (n=340)
99.0% (n=293)

1, “--”: data not determined; 2, “#”: value calculated by using data from the references.
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Figure 1-3, Global distribution of IDV by country. Red: IDV positive in humans and animal
species; Orange: IDV positive in animal species; Gray: no data or no positives reported. IDV was
found in America, Canada, and Mexico in North America; China, Japan and Turkey in Asia;
France, Italy, United Kingdom, Ireland and Luxembourg in Europe; Morocco, Togo, Benin,
Ethiopia and Kenya in Africa. Circled numbers indicate the reported presence of IDV lineages.
①: D/OK lineage; ②: D/660 lineage; ③: D/Japan lineage.

1.2.1.3 IDV in Asia

IDV in Asia was first reported in 2014 in Shandong, China, with 3 IDV-positive cases
out of the 453 samples collected from apparently healthy cattle (62) (Table 1-2). A
subsequent surveillance study in China showed a high prevalence (> 30%) of IDV in pigs
and goats (63) (Table 1-2) , which was different from the relatively low prevalence found
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in previous studies (4, 23, 50). Notably, this study showed that IDV genome was present
in serum samples of severely diseased cattle and goats, implying that the virus might
enter transiently into the animals’ circulatory system and spread to other organs (63).
Another interesting observation from this study was that IDV was detected in goat rectal
swabs, which suggested that IDV might replicate within the intestinal tract similar to IAV
and IBV (63, 70). IDV genome was also found in buffalo from this study (63).

The first identification of IDV in Japan was reported from a cattle herd in the Ibaraki
Prefecture in 2016 (64). In this study, IDV showed highly contagious property, in which
the virus readily spread throughout the herd in a short time once the IDV infection
occurred (64). Further serological surveys indicated that IDV had been in nationwide
circulation in the cattle population of Japan for at least 5 years, with an overall positivity
rate of 30.5% (n=1267) (66) (Table 1-2). The positivity rates of IDV infection tended to
increase with the cattle age when analyzing the seropositive cattle with the age records at
the time of collection (66). IDV-specific antibodies were detected in samples collected in
as early as 2010, suggesting that IDV exposures were present in Japan since at least 2010
(66). Most recently, infection of cattle with IDV was also reported for the first time in
Turkey (67).

Phylogenetic analysis revealed that all IDV strains isolated in China belonged to the
D/OK genetic cluster (63) (Figure 1-2). Interestingly, IDV circulating in Japan formed a
different genetic cluster (termed as D/Japan) from the D/OK and D/660 genetic clusters,
suggesting a possibility of unique evolution of IDV in Japan over a long period of time (5,
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65) (Figure 1-2). Just recently, a new IDV isolate from diseased cattle in Japan was found
to be phylogenetically and antigenically distinguished from all previously described IDVs
of the 3 known lineages (71). Further studies are needed to elucidate prevalence,
epidemic status and pathogenicity of this heterologous IDV (71).

1.2.1.4 IDV in Africa

IDV has been identified in several continents including North America, Europe and Asia.
Recently, a study reported the prevalence of IDV for the first time in Africa, by
performing the HI assay on a total of 2083 serum samples from cattle, swine, small
ruminants, and dromedary camels in Morocco, Togo, Côte d’Ivoire, Benin, and Kenya
during 1991-2015 (26). The results showed that IDV antibodies were detected in cattle
from Morocco (2012-2015), Togo and Benin (as of 2014), and in small ruminants from
Togo (2013) (Table 1-2), suggesting that IDV had been circulating in North and West
Africa since at least 2012 (26). Significantly, the authors also showed that dromedary
camels exhibited extremely high seropositivity (99.0%) for IDV in Kenya (Table 1-2),
indicating a new host for IDV (26). This was further confirmed by another serological
survey in Ethiopia where a high seroprevalence of IDV was also observed in dromedary
camels (68). Future studies are needed to illustrate the role of camels on the
epidemiology, ecology and pathology of IDV. To date, IDV infection has been
demonstrated in Morocco, Togo, Benin, and Kenya in Africa by serological evidences,
but the virus has not yet been isolated on this continent (26, 68, 69).
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1.2.2 Pathogenicity and zoonotic potential of IDV

1.2.2.1 Pathogenicity of IDV in swine and cattle

Table 1-3. Replication, pathogenicity and transmission of IDV in experimentally infected
animals.
Animal species

Replication

Pathogenicity

Transmissibility

Domestic pigs

Upper respiratory tract

No clinical signs

Contact-transmission

No clinical signs

Contact-transmission

Feral pigs

Cattle
Ferrets
Guinea pigs

Both the upper and lower
respiratory tracts
Both the upper and lower
respiratory tracts
Nasal turbinates
Both the upper and lower
respiratory tracts

Mild respiratory disease

Contact- or aerosoltransmission

No clinical signs

Contact-transmission

No clinical signs

Contact-transmission

No clinical signs

NA

Mainly in upper respiratory
Mice

tract with a lower extent in the
lower respiratory tract

IDV has a worldwide distribution (Figure 1-3) and can infect multiple animal species
(Table 1-2). It was first isolated from pigs with influenza-like illness (4). Two
surveillance studies reported that IDV RNA was detected in pig lung samples, implying
IDV infection in the lower respiratory tract (58, 63). However, domestic pigs
experimentally infected with IDV exhibited no clinical signs of illness (4) (Table 1-3). In
addition, this study revealed that IDV infection was limited to the upper respiratory tract
of pigs (4) (Table 1-3) . Interestingly, an infection experiment conducted on feral swine
showed that IDV was able to replicate in both the upper and lower respiratory tracts
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including nasal turbinate, soft palate, trachea, and lung tissues, but no clinical signs were
observed (48) (Table 1-3). Moreover, IDV viremia was detected in the infected feral
swine (48). A recent animal study indicated that IDV infection caused lung lesions in
pigs with the existence of IAV-specific antibodies (72). These different observations
regarding the pathogenesis of IDV in swine might be affected by animal types, study
conditions, and virus strains. However, all these animal studies pointed out that IDV was
transmissible among pigs by direct contact (4, 48, 72). Further studies are needed to
clarify the pathogenesis and transmission of IDV in swine because diseases sometimes
can be readily transmitted from swine to humans and other animal species.

Cattle are the primary reservoir for IDV. Several surveillance studies showed that more
IDV RNA was detected in diseased cattle than that in healthy cattle (40, 43, 63, 73). The
three metagenomic studies performed on cattle with BRD found a positive correlation
between BRD and IDV infection (43, 44, 73). However, appreciable levels of IDV RNA
were also detected in healthy cattle (40, 52, 57). To further determine the pathogenesis
and transmission of IDV, several experimental studies were conducted on IDV-negative
cattle (Table 1-3). These animal studies indicated that IDV could cause mild respiratory
disease in experimentally infected cattle (74-77). Two of them demonstrated that IDV
replicated in both the upper and lower respiratory tracts (75, 76). Inflammations
characterized by neutrophils were observed in the nasal turbinate (74), trachea (74, 75),
or bronchial lumens (76). Importantly, these studies also confirmed that IDV could be
transmitted between cattle through direct contact or aerosol (75, 76). Overall, cattle, as
the natural reservoir of the virus, play an important role in IDV replication and
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transmission, which emphasizes the need for continued monitoring and risk assessment of
this emerging virus in cattle.

As stated above, IDV was highly associated with BRD that is triggered by complex
interactions between host, infectious agents, and environmental factors (78). Generally,
cattle with stress and under adverse environmental conditions are susceptible to a primary
viral infection and the compromised host immunity caused by the viral infection
facilitates a secondary bacterial invasion of the respiratory tract, which may lead to
severe disease or death in the animals (77, 78). Viruses including bovine viral diarrhea
virus, infectious bovine rhinotracheitis virus, bovine respiratory syncytial virus,
parainfluenza type-3 virus and the newly identified IDV, and bacteria such as
Mannheimia haemolytica (MHA), Pasteurella multocida, Histophilus somni, and
Mycoplasma bovis are considered important pathogens for BRD (43, 44, 73, 77). To
determine the potential role of IDV in BRD when IDV infection accompanied with a
secondary bacterial infection, an animal study was designed on cattle co-infected with
IDV and MHA. The results showed that primary IDV infection in cattle did not enhance
the disease caused by the secondary MHA infection (77). Interestingly, this result was
similar to that of an independent mice study, which found that IDV infection in mice did
not increase the susceptibility to the secondary Staphylococcus aureus infection but was
protective against clinical signs of the secondary bacterial infection (79). More studies
are needed to define synergistic or antagonistic actions behind the opportunistic infection
with IDV and determine the underlying mechanisms of IDV pathogenicity in the setting
of primary viral infection and secondary bacterial superinfection.
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1.2.2.2 Pathogenicity of IDV in other animals

Besides swine and cattle, IDV was found to infect other animal species including sheep,
goats, equine, buffalo, and camels in the field (23, 24, 26, 56, 57, 63, 68). However, the
pathogenicity of IDV in these animals remains unclear. A surveillance study in China
reported IDV viremia in 33.8% (n=80) of the goats with severe diseases (63). The
presence of influenza viremia can be used as an indicator of the level of the disease
severity (80), but the relatedness requires further validation.

The pathogenicity and transmissibility of IDV was also determined by experimental
infection of ferrets, guinea pigs, and mice (Table 1-3). These laboratory animals are
widely used in influenza A and B research. No clinical signs of disease were observed in
these animals infected with IDVs, respectively (4, 79, 81, 82). In ferrets, IDV replicated
in nasal turbinates but not in the lower respiratory tract (4).

The virus could be

transmitted to naïve ferrets by direct contact (4). In contrast to ferrets, IDV in guinea pigs
was detected in both the upper and lower respiratory tracts, and could also be transmitted
to the sentinels by direct contact (82). IDV replication in mice was observed mainly in
the upper respiratory tract but also to a lower extent in the lower respiratory tract (81).
Importantly, the virus was detected with low titers in mice intestines (81), which was in
agreement with a recent study that found IDV in rectal swabs of goats (63). This enteric
tropism of IDV seems to be supported by a studying showing the exceptional acid
stability of IDV when compared to other types of influenza. It may be interesting to test
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whether IDV can use a fecal-oral transmission route to replicate and transmit among
animals.

1.2.2.3 Zoonotic potential of IDV

There are no indications so far that IDV can cause disease in humans. However, IDV is
the emerging influenza virus that has a broad host range, which is similar to IAV. As
mentioned above, IDV can infect and/or to be transmitted to multiple domestic animals
including cattle, pigs, sheep, goats, camels, horses, and poultry, and also to wild species
such as feral pigs. In addition, IDV is able to replicate and transmit by direct contact in
ferrets and guinea pigs, both surrogate models for influenza virus studies in humans (4,
82). Furthermore, IDV showed a broad cellular tropism in the cell culture studies (4). A
recent study confirmed that IDV was able to efficiently replicate in the well-differentiated
human airway epithelial cells (hAECs) that served as an in vitro respiratory epithelium
model of humans (83). This model has been well applied to assess the zoonotic potential
of emerging respiratory viruses (84, 85). Generally, successful zoonotic infections occur
when the pathogens acquire the ability to cross the species barrier and replicate
efficiently in a novel host species (86). Taken together, these findings suggest that
multiple-species-infecting IDV has the great zoonotic potential.

Several serologic studies have demonstrated that IDV-specific antibodies could be
detected in humans. An early serosurvey showed that 1.3% (n=316) of the general human
population had antibodies against IDV (4), while no IDV was detect in patient respiratory
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samples by RT-PCR from a later large-scale surveillance study in Scotland (87). Notably,
a very high seroprevalence of IDV was observed among workers with cattle exposure (34
out of 35 persons had IDV antibodies), as reported in a serological study in Florida, USA
(25). Recently, a more comprehensive seroprevalence study revealed that IDV antibodies
were present and increased over time in the Italian populations from 2005 to 2017 (61).
The results showed that antibodies against IDV displayed low levels (5.1%-9.8%) in the
years 2005-2007, and sharply increased to high levels (37.9%-43.4%) in the years 20082010 and (41.0%-46.0%) in the years 2013-2014, followed by a decline in the subsequent
years 2011-2012 and 2015-2017 (61). Interestingly, this longitudinal study revealed a
temporal correlation between IDV prevalence peak in humans and epidemics in domestic
pigs in Italy. The prevalence of antibodies against IDV in humans implies that the virus
may infect humans and pose a threat to human health.

Interestingly, an aerosol surveillance of respiratory viruses at the Raleigh-Durham
International Airport observed that among 4 of the 24 samples positive for known
respiratory pathogens, 3 were positive for adenovirus and 1 was positive for IDV (88).
Similarly, IDV was detected in another molecular surveillance of respiratory pathogens
with bioaerosol sampling in a hospital emergency room setting in North Carolina (89).
Significantly, a more recent study showed that the IDV RNA genome was detected in
nasal wash samples of a swine farm worker in Malaysia, Asia (90). Although these
observations are not enough to indicate the public health threat of IDV, it is considerable
that the virus may have spread into the public environment including humans.
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1.2.3 Novel biology of IDV

IDV, an emerging type of influenza viruses, with a potential threat to humans, has a
broad host range and a global distribution. Moreover, IDV is a new virus with novel
biological characteristics among the four influenza genera. IDV was found to be the most
stable of the four types of influenza viruses. Only IDV was still infectious after a 15minute exposure to 53 ℃ in the neutral solution, and surprisingly, it maintained the
infectivity even after exposure to 53 ℃ for 2 hours (90). Furthermore, IDV survived after
being treated at pH 3.0 for 30 minutes, while all other types of influenza viruses were
completely inactivated (90). The recombinant IAV whose HA and NA were replaced
with HEF of IDV acquired the ability to resist the high-temperature and low-pH
treatments, which was the same as the HEF donor virus (IDV) (91). These observations
demonstrated that the HEF determined the exceptional thermal and acid stability of IDV.
Since the acid stability of HA has been found to impact the host range, infectivity, and
transmissibility of IAV (92), further studies on the mechanism by which HEF confers the
environmental stability to IDV may offer new insights into the interspecies adaptation
and transmission of the novel IDV. In addition, this unique property of IDV may partially
explain why IDV, but not IAV, IBV or ICV, could be detected in people or patients
through the molecular surveillance of respiratory viruses with bioaerosol sampling in the
airport or in a hospital emergence room (88).

The spike glycoproteins of influenza viruses mediate the viral entry into the host cells via
recognition and interaction with the SA receptors. Recent structural and functional
studies of the HEF suggested that its unique receptor-binding pocket might contribute to
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the broad host range of IDV. The functional form of the spike is a homotrimer (Figure 14). The overall structures of IAV and IBV HAs are similar, despite sharing a very low
sequence identity of only 20%-30% (18). During the viral life cycle, HA is primarily
synthesized as a precursor (HA0) that is subsequently cleaved into the globular HA1
subunit and the stalk-like HA2 subunit (93, 94). The major domains of the HA protein
include the R domain, containing the receptor binding pocket (RBP), the E domain which
has a vestigial esterase region, and the F domain, with the fusion peptide that mediates
the fusion between the viral and host membrane (93-95) (Figure 1-4). HEFs of ICV and
IDV have 53% amino acid homology (4) and possess a almost identical structure and
mode of ligand binding (20, 29). Similar to HA, HEF is synthesized as a precursor (HEF0)
that is composed of two post-translationally cleavable subunits: the globular head subunit
HEF1 and the membrane-near stalk subunit HEF2 (20, 29). HEF also can be divided into
three domains: the receptor binding domain (R), the esterase domain (E) and the fusion
domain (F) (20, 29) (Figure 1-4). HEF contains the esterase activity in the E domain
while it is degenerated in HA. One interesting difference between ICV HEF and IDV
HEF is that IDV HEF protein has an open channel in the RBP, while in the structurally
identical site of ICV, there is a salt bridge formed by the positively-charged residue
Lysine (K235) and the negatively-charged residue Aspartate (D269) (29). The equivalent
positions of IDV HEF are T239 and A273 which cannot form the salt bridge interaction
(29). This subtle difference may indicate that IDV has different receptor-binding
properties compared to ICV. Further functional studies demonstrated that IDV HEF was
able to efficiently bind both Neu5,9Ac2 and Neu5Gc9Ac as the receptors, while ICV
preferentially bound to Neu5,9Ac2 as its receptor (30). Taken together, the open and
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flexible receptor-binding cavity of HEF may allow IDV to recognize more diverse 9-Oacetyl SAs, which further broaden its cell tropism and host range.

Figure 1-4, Schematic illustration of the HA/HEF. Linear order of the sequence fragments in
HA/HEF colored by domains: fusion domain (F1, F2, and F3, red), esterase domain (E1, E1’, and
E2 in the HEF, blue; only E1’ in the HA, gray), receptor domain (R, green), fusion peptide (FP),
and transmembrane region (TM).

Influenza viruses have evolved different strategies to produce the viral proteins to
maximize the genome coding potential. Splicing has been demonstrated in the NS and/or
M segments of influenza viruses. All types of influenza viruses possess a similar
mechanism to generate the NS1 and NS2 proteins (21, 96) (Figure 1-5). Generally, the
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NS1 protein is encoded by a colinear mRNA transcript from the first initiation codon of
the NS segment, while the NS2 protein is encoded by a spliced mRNA transcript from the
NS segment, which shares the first portion within the NS1 transcript and switches to the
second portion within the 3’ end of the NS segment (Figure 1-5). However, each type of
influenza viruses uses unique strategy to produce M1 and/or M2 proteins (Figure 1-5). In
IAV, M1 protein is made from an unspliced colinear mRNA but M2 protein is
synthesized by using a spliced mRNA template (97), which is similar to the production of
NS1 and NS2 proteins (Figure 1-5). In contrast, the M segment of IBV is not spliced.
IBV M1 protein is encoded by a colinear transcript, and M2 protein is generated via a
translational stop-start mechanism (98) (Figure 1-5). Whereas ICV M1 mRNA needs to
be spliced to create a termination codon, while its M2 protein is derived from the
proteolytic cleavage of a P42 propeptide encoded by an unspliced colinear mRNA (99,
100) (Figure 1-5). IDV uses the proteolytic cleavage strategy similar to that of ICV to
generate M2 protein from the P42 protein (9), while in contrast to the ICV M segment
that generates the M1 protein via splicing that only introduces a termination codon, the
splicing of IDV M segment produces additional 4-amino-acid peptide into the preceding
exon (21). The function of these four amino acids is still unclear. Recently, a study
reported that IAV M segment RNA splicing was an important host range determinant
(101). It would be interesting to speculate that different mechanisms for production of
M1 and M2 proteins among four types of influenza viruses may determine the viral
evolution and host range, which should be tested experimentally in future studies.
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Figure 1-5, Splicing strategies of influenza viruses for the NS and M segments.
(Modified from Andrew M.Q. King, et al., Virus Taxonomy: Ninth Report of the
International Committee on Taxonomy of Viruses, 2012, Pages 752-753)

1.3 Research Aims

1.3.1 Hypothesis

The factors determining the infectivity and transmissibility of influenza viruses could
include the viral, host and environmental factors. IAV originally infects waterbirds and
can cross the species barrier to infect humans and numerous other animal species. IBV
and ICV mainly infect humans. IDV is unique among four types of influenza viruses to
utilize cattle as the primary reservoir and can spread to many other agricultural animals.
The environment plays an important role in driving IAV persistence and transmission in
natural and acquired hosts. It is unknow how IDV performs in different environments.
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IDV has a worldwide distribution and a broad host range and possesses potential to adapt
to humans. IDV shows optimal growth at both 33 °C and 37 °C, unlike its related ICV
that is typically replicated well at 33 °C, which suggests that IDV is not restricted to an
elevated temperature for replication. IDV has a broad receptor-binding property. IDV has
also evolved a unique strategy to produce the M1 protein. IDV has such important
properties but the underlying mechanisms remain unclear, we ungently need a reverse
genetics system to study IDV in molecular level.

Reverse genetics system is widely used to study viral replication, tropism, and
pathogenesis. IDV can be divided into three genetic lineages: D/OK, D/660 and D/Japan.
The D/OK virus and the D/660 virus are two lineage-representative IDV strains. Our
primary studies showed that the D/660 virus had a higher replication capacity than that of
the D/OK virus. Further studies confirmed that the D/660 virus replicated more robust
than the D/OK virus in different cell lines, which indicated that the replication difference
between the D/660 and D/OK viruses was host cell – independent. Some viral factors
may determine the IDV replication fitness.

1.3.2 Specific Aims

Project 1: To investigate the thermo and acid stability of influenza viruses.
Project 2: To generate and characterize the reverse genetics system of IDV.
Project 3: To identify genetic determinants of IDV replication fitness.
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2.1 Introduction

Influenza viruses are segmented, single-stranded, negative-sense, enveloped RNA viruses
and belong to the Orthomyxoviridae family. Four types of influenza viruses, designated
influenza A virus (IAV), influenza B virus (IBV), influenza C virus (ICV), and influenza
D virus (IDV), have been identified. The genomes of IAV and IBV consist of eight RNA
segments, whereas ICV and IDV have only seven segments. IAV and IBV contain two
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major surface glycoproteins: hemagglutinin (HA), which binds to sialylated host cell
receptors and mediates membrane fusion, and neuraminidase (NA), which prevents the
HA from host cell membrane engagement by cleaving sialic acids from receptors, thereby
releasing newly assembled virus particles (34). ICV and IDV, however, have only one
major surface glycoprotein, the hemagglutinin-esterase fusion (HEF) protein, which
performs all above functions, including receptor binding, receptor destroying, and
membrane fusion (4). IAV infects avian, human, swine, and many other mammalian
species, including tigers, seals, dogs, and horses, while IBV and ICV are found
principally in humans and rarely infect other species. The recently discovered IDV causes
respiratory diseases primarily in cattle and to a lesser extent in pigs. Moreover,
serological evidence for IDV infection in small ruminants and humans has been
established (23, 25). Since the initial isolation of IDV in the United States in 2011, IDV
has been reported in China, Mexico, France, Italy, and Japan. Under experimental
conditions, IDV is capable of infecting ferrets and guinea pigs and transmitting to naïve
animals by direct contact (4, 82).

IDV differs from all historically known influenza viruses in that it utilizes cattle as a
primary reservoir. Adaptation to cattle may confer some unique features to IDV, which
enhance its survival in this particular agricultural animal population. Such inherited
characteristics through evolution may make IDV distinguishable from other types of
influenza viruses circulating in ducks, pigs, or humans. As a first step toward identifying
novel biological traits and better understanding the infection biology of newly emerging
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IDV, we directly compared the stability and infectivity of IDV to those of other influenza
types following exposure to either high temperatures or low-pH solution. Interestingly,
our experiments revealed that IDV was more resistant to high temperatures and highly
acidic environments than the other three types of influenza viruses. Significantly, we
found that the viral HEF glycoprotein is a primary force in dictating the exceptional
stability of IDV infectivity at low pH and high heat.

2.2 Methods, results and discussion

The viruses used in this study are listed in Figure 2-1A, including two IAVs (originated
from swine and human), one IBV (from human), one ICV (from human), and two IDVs
(from cattle and swine). We started by investigating the effect of temperature on the
stability and infectivity of the influenza viruses. Temperature gradients evaluated
included 33°C, 37°C, 41°C, 45°C, 49°C, 53°C, 57°C, and 65°C. A temperature of 0°C
was included as a control. All the viruses listed in Figure 2-1A were treated under this set
of temperatures for 1 h at neutral pH and then incubated on ice for another 30 min. After
treatment, the infectivity of these viruses was determined by measuring viral 50% tissue
culture infective doses (TCID50s) in MDCK (Madin-Darby canine kidney) cells using
the standard protocol (102, 103). Viral titers for all tested viruses were not impaired when
treated at 33 to 41°C but started to decline at 49°C (Figure 2-1B). The 53°C treatment
clearly discriminated IDV D/OK/13 (see Figure 2-1A for the influenza virus strains and
influenza virus abbreviations) from the three other types in that IDV retained a high
residual infectivity (~2.5 log units of TCID50/ml), while IAV, IBV, and ICV were
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completely inactivated. Remarkably, IDV was still infectious when treated at 57°C, and
the complete loss of its infectivity was observed only after 1 h of incubation at 65°C.

Figure 2-1. Thermal and pH stability of influenza viruses. (A) A list of the influenza viruses used
in this study and their infectivity determined as TCID50 per ml in MDCK (Madin-Darby canine
kidney) cells. These viruses were replicated in MDCK cells under the same conditions. (B) All
viruses were treated in solution under different temperatures for 60 min and incubated for another
30 min in 4°C prior to the infectivity experiment. Note that the virus titers were 5.4 log10
TCID50/ml for A/MN/08, 5.6 log10 TCID50/ml for A/CA/09, and 5.6 log10 TCID50/ml for
B/BR/08, which are slightly different from those used for the experiments shown in panels C and
D. (C) A/MN/08, A/CA/09, B/BR/08, C/JHB/66, and D/OK/13 were treated in solution under
53°C for different time points and incubated for another 30 min in 4°C prior to the infectivity
experiment. (D) A/MN/08, A/CA/09, B/BR/08, C/JHB/66, and D/OK/13 were treated in solution
with different pH values for 30 min at room temperature, followed by neutralization and
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incubation for another 30 min in 4°C prior to the infectivity experiment. The data presented in
this figure are representative of three independent experiments, with each assay sample tested in
duplicate. The error bars represent standard deviations and indicate the variations among the
experiments.

We next selected the 53°C treatment condition at neutral pH with different time points
after incubation (0, 15, 30, 45, 60, and 120 min) to directly study the thermal stability and
infectivity of all types of influenza viruses (Figure 2-1C). Significantly, only D/OK/13
was able to tolerate the high temperature of 53°C. All other types of influenza viruses,
such as A/MN/08, A/CA/09 (pdm09HIN1), B/BR/08, and C/JHB/66, completely lost
their capacity to survive when exposed to 53°C for 15 min (Figure 2-1C). Notably,
D/OK/13 was able to maintain about 40% of its infectious titer for 2 h (Figure 2-1C).
These results suggested that IDV is the most temperature-stable influenza type of all
influenza virus types.

In parallel, we directly studied the stability and infectivity of these viruses (Figure 2-1A)
at different pH values ranging from 3.0 to 7.0. For pH trials, 0.2 M sodium acetate-acetic
acid buffer was adjusted from pH 3.0 to 7.0 at 1-unit increments with the addition of 10%
HCl. A nontreated control (NTC) was also included in the analysis. All pH trials were
completed at room temperature for 30 min. Each pH treatment was measured at the start
of the study and confirmed at the completion of each trial. In all cases, it did not vary
more than 0.2 unit from the starting pH value. Then, treated viruses were pH neutralized
with infection medium and incubated for additional 30 min at 4°C followed by measuring
their TCID50 in MDCK cells using the same protocol described above. Remarkably,
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D/OK/13 was determined to be the most stable influenza virus when treated with a pH of
as low as 3.0 (Figure 2-1D). The virus retained about 80% of its original infectivity at pH
3.0, whereas all other types of influenza viruses completely lost their infectivity at a pH
of 3.0 (Figure 2-1D). Interestingly, IBV was found to be the most unstable influenza
virus and lost its infectivity at pH values below 5.0 (Figure 2-1D), followed by the two
IAVs (completely inactivated at pH 4.0). It is interesting to note that ICV, evolutionarily
and genetically close to IDV, also acquired appreciable resistance to more acidic
environments. For example, despite becoming noninfectious at pH 3.0, ICV retained
approximately 60% of its infectivity at pH 4.0. Overall, the ranking in order of the
inherent stability at low pH is as follows: IDV > ICV > IAV > IBV. Together, the results
of our experiments indicated that IDV is the most stable influenza virus in a low-pH
environment.

Premature activation of viral fusion peptide is detrimental to influenza A virus infectivity
(104). Previous studies have established that pretreating IAV prior to infection of cells by
exposing the virus to high temperature or low pH can cause premature exposure of the
viral fusion peptide in the HA protein, which leads to an irreversible loss of viral
infectivity (104, 105). Interestingly, IDV and to a lesser extent ICV, exhibiting a good
acid stability (Figure 2-1D), both harbor the HEF protein on the virion surface. The HEF
protein in IDV and ICV, like HA in IAV and IBV, mediates virus entry and virus-cell
membrane fusion in intracellular endosome compartments in an acidic environment. On
the basis of the above analysis, we hypothesize that the viral HEF glycoprotein is a
primary determinant of the thermal and acid stability of IDV. To test this hypothesis, the
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HA and NA segments of an IAV H1N1 WSN/1933 (A/WSN/33) were replaced with the
HEF segment of D/OK/11 (from swine) using the reverse genetic system (Figure 2-2A),
and the stability and infectivity of the rescued A/D-HEF chimeric virus were examined
and directly compared with its parental viruses (A/WSN/33 and D/OK/11) by the
protocol discussed above. As demonstrated in Figure 2-2B, A/WSN/33 (wild type)
completely lost its infectivity when treated at 53°C for 15 min. In marked contrast, the
A/D-HEF chimera was able to survive and maintain its infectious titer after exposure to
53°C for up to 120 min, which was the same as for wild-type D/OK/11 (the HEF protein
donor).

Figure 2-2. HEF is a key determinant of the exceptional acid and temperature stability of IDV.
(A) Schematic representation of A/WSN/33, D/OK/11, and chimeric A/D-HEF viruses used in
this study. Specifically, we generated a D/OK/11 HEF expression plasmid in the context of
pHW2000-derived dual-promoter reverse genetic system (RGS) expression construct of the
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A/WSN/33 neuraminidase (NA) segment. The complete HEF cDNA from D/OK/11 is flanked by
183 nucleotides of the 3’ NA viral RNA (vRNA) and 157 nucleotides of the 5’ NA vRNA, and
initiation codons in the 3’ NA vRNA are mutated to express HEF protein only. Chimeric A/DHEF virus was generated through cotransfection of 293T and MDCK cells with the chimeric HEF
plasmid together with A/WSN/33-derived PA, PB1, PB2, NP (nucleoprotein), M (matrix), and
NS (nonstructural) RGS plasmids. (B) A/WSN/33, IDV D/OK/11, and chimeric A/D-HEF were
treated in solution at 53°C for different times, followed by incubation in 4°C for 30 min prior to
infection experiments. (C) A/WSN/33, D/OK/11, and chimeric A/D-HEF were treated in solution
over a range of pH values from pH 3.0 to 7.0 for 30 min, followed by neutralization and
incubation for another 30 min in 4°C prior to the infectivity experiment. The data presented in
this figure are representative of three independent experiments, with each assay sample tested in
duplicate. The error bars represent standard deviations and indicate the variations among
experiments.

Furthermore, following exposure to different pH environments from pH 3.0 to 7.0, the
A/WSN/33, like other two IAVs (Figure 2-1D), completely lost its infectivity after
exposure to pH 5.0 or below (Figure 2-2C). Remarkably, at pH 5.0, the A/D-HEF
chimera lost only about 15% of its infectivity. The chimera still retained more than 50%
of its infectivity at pH 4.0 but was completely inactivated only at pH 3.0. Similar to
D/OK/13, which originated in cattle (Figure 2-1D), D/OK/11 (swine origin) also survived
when held in solution for 30 min at pH 3.0. In summary, these results suggested that the
HEF protein is a key factor in determining IDV’s exceptional plasticity in response to
high-temperature stress and a low-pH environment. It should be noted that the HEF
protein, in the context of the A/D-HEF chimeric virus, did not make the chimera fully
gain the acid resistance trait as demonstrated in wild-type D/OK/11 (Figure 2-2C) or
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D/OK/13 (Figure 2-1D). This discrepancy may be caused by the subtle difference of the
density and spatial arrangement of the HEF protein on the virion surface between the
chimeric IAV and native IDV, which will be investigated in future studies.

Intriguingly, acquisition of this remarkable physicochemical stability has apparently not
inhibited the ability of IDV to spread efficiently in global animal herds. Such stability
may give IDV additional advantage in surviving well in harsh environmental conditions,
such as heat and low pH. Relating both thermal and acidic stability of IDV to the HEF
protein is very similar to recent results with the HA protein of IAV where it was shown
that some HA mutations lowering the pH threshold in activation of the HA fusion peptide
(i.e., increased acid resistance) evidently rendered the IAVs more resistant to heat (106110). As such, the HA protein of IAV appears to follow IDV in gradually acquiring
acidic and thermal stability. Although the mechanism is still largely unknown, it is
generally believed that some animal IAVs (swine or poultry) conducting a virus-cell
membrane fusion event at a lower pH can transmit more efficiently to humans than those
fusing at a higher pH (111). Therefore, the increased acid stability and thermostability of
HA have been viewed as important requirement, in addition to the receptor binding
specificity/affinity, for efficient airborne transmission of IAVs from animals to humans.
A recent work also showed that the neuraminidase protein of the 1918 pandemic IAV is
relatively stable at low pH, and this low-pH stability is implicated in enhancement of
virus replication (112). In light of the above facts, further investigation of the molecular
mechanism by which naturally stable IDV enters the cell and fuses with the host
membrane may offer novel insights into how the fusion machinery of influenza viruses in
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general evolves, directed by viral glycoproteins, to achieve higher acid and thermal
stability, which as a result promotes the cross-species transmission potential between
mammals.

The observation of viral HEF protein conferring exceptional resistance to high
temperature and low pH raises several interesting questions with respect to the entry
pathway and biology of IDV. First, can acidification artificially transform IDV into a
fusogenic stage (i.e., fusion peptide completely exposed)? If so, we would anticipate that
low-pH-induced fusogenic IDV would not be infectious. On the basis of our data that the
pretreatment of IDV in a low-pH buffer prior to incubation with cells had no substantial
effect on viral infectivity, while this treatment completely inactivated IAV, we speculate
that low pH is required but not sufficient to trigger complete activation of the IDV fusion
peptide, although we cannot rule out the possibility that activation of IDV’s fusion
activity is pH independent or that IDV HEF conformational changes triggered by low pH
leading to viral fusion are reversible (instead of IAV-like irreversible). Second, is there a
requirement for cellular acidification in IDV entry? Previous studies have demonstrated
that IDV-related ICV requires a low-pH-dependent fusion in cells (113, 114).
Interestingly, an earlier ICV fusion characterization study revealed that ICV fused with in
vitro-reconstituted liposomes relatively slower than IAV or IBV did (114). The time
delay in fusion may reflect the more stable nature of the HEF protein of ICV in a low-pH
environment, which is demonstrated in our study (Figure 2-1D). On the basis of the
results of the above analysis, we speculate that IDV will likely utilize a low-pH
dependent endocytosis route, the common pathway for all influenza viruses, to enter the
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cell and fuse with the endosomal membrane to initiate infection. Third, what is the
primary mechanism employed by IDV to activate the virus-cell membrane fusion event?
Here, we propose three models for IDV fusion mechanism. The first test model is that in
addition to low pH, receptor binding may play a critical role in priming IDV fusion, a
mechanism used by avian sarcoma and leucosis virus (ASLV) (115), Jaagsiekte sheep
retrovirus (116), and hepatitis C virus (117). It is interesting to note that ASLV, like IDV,
is resistant to inactivation by low pH. The second model is that some cellular factors in
acidic intracellular compartments may be required for activation of IDV fusion as
observed for Ebola virus and severe acute respiratory syndrome coronavirus (SARS-CoV)
(118, 119). The third model is that intracellular processing of IDV could trigger some
changes in the trimeric structure of the HEF protein, which in turn activates the IDV
fusion peptide and drives the virus-cell membrane fusion. This model has been
previously suggested for acid-resistant bovine pestivirus in activation of pH-triggered
fusion during viral entry (120). Further investigation of these hypothetical models is
needed to achieve a better understanding of the entry and fusion mechanisms mediated by
the intrinsically stable HEF protein of IDV. Such information may offer novel insights
into how the fusion machinery of influenza viruses in general evolves to achieve the acid
and thermal tolerance, which as a result promotes the potential to transmit across
mammal species.
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3.1 Introduction

Influenza viruses are enveloped, segmented, single-stranded, negative-sense RNA viruses
that belong to the Orthomyxoviridae family. Four influenza types, A, B, C, and D are
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classified on the basis of antigenic differences in the nucleoprotein (NP) and the matrix
protein (M). Among these four types, influenza A virus (IAV) is the most common and
the most pathogenic, causing seasonal epidemics every year in the Northern and Southern
hemispheres and periodic pandemics (121). Despite lacking the ability to trigger
pandemics, influenza B virus (IBV) also causes annual epidemics frequently associated
with deaths in people (18). Influenza C virus (ICV) is generally not associated with
annual influenza epidemics and gives rise to only mild respiratory infections in humans
(20). Influenza D virus (IDV) was first isolated in 2011 (4) and officially named in 2016
(https://www.cdc.gov/flu/about/viruses/types.htm). Soon after its discovery, similar
viruses were successively identified from swine and/or cattle in North and Central
America, Asia, Europe, and Africa ((23, 40, 41, 43, 49, 50, 52, 53, 58, 62-64)). It was
shown that IDV utilizes cattle as a primary reservoir and amplification host, with
periodical spillover to other mammalian hosts (21, 22). In addition to swine and bovines,
antibodies against IDV were detected in sera from small ruminants (goats and sheep),
horses, camels, and humans (especially cattle workers) (22-26, 41). Significantly, a more
recent study showed that the IDV genome was detected in nasal wash samples of a swine
farm worker in Malaysia, Asia (90). Furthermore, molecular surveillance of respiratory
viruses with bioaerosol sampling in the Raleigh-Durham International Airport found that
among 4 (17%) of the 24 samples positive for known respiratory pathogens, 1 was
positive specifically for IDV (88). It should be noted that none of the 24 samples tested
positive for influenza A, B, and C viruses. Using a similar approach, one study detected
IDV in hospital visitors in North Carolina (89). In addition to these epidemiological
studies, several clinical studies were performed in cattle, showing that IDV replication
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can damage the structure of epithelial cells lining the respiratory tract and cause mild
respiratory disease in infected animals (4, 75, 76). Considering the worldwide distribution
and broad host range of IDV and its potential to adapt to humans, it is necessary to
further characterize this novel influenza virus at the molecular level.

Unlike the genomes of IAV and IBV that consist of eight segments, ICV and IDV contain
only seven genome segments. The three longest segments of IDV encode the polymerase
subunits PB2, PB1, and P3, which form a heterotrimer to catalyze the transcription and
replication of the viral genome RNA (vRNA). Transcription of vRNA to mRNA starts
with the “cap-snatching” reaction, a process during which capped RNAs are bound by the
cap-binding domain of the PB2 subunit and cleaved by the endonuclease of the P3
subunit; actual RNA synthesis is performed by the PB1 subunit that forms the core
structure of the heterotrimeric RNA polymerase complex (22, 122). The fourth segment
produces a major surface glycoprotein, the hemagglutinin-esterase fusion (HEF), which
harbors viral receptor-binding, receptor-destroying, and membrane fusion activities (4,
29). The fifth segment encodes the nucleoprotein (NP), which, together with the vRNA
and the polymerase complex, forms the ribonucleoprotein (RNP) complex. Each vRNA
segment forms an RNP complex, and the RNP is the fundamental unit for vRNA
transcription and replication (29). The sixth segment encodes the matrix proteins DM1
and DM2, and the DM2 protein exhibits the ion channel activity (9). The last segment
produces two nonstructural proteins, NS1 and NS2. To date, the biological function of the
individual proteins of IAV has been well studied, while very limited work has been
performed to characterize functions of IDV proteins.
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Reverse genetics is one of the most powerful tools to study the biological properties and
molecular characteristics of influenza viruses. But until now, no system for the rescue of
IDV has been reported. Over the past 20 years and more, several plasmid-based systems
for the rescue of recombinant IAV, IBV, and ICV have been successfully developed
(123-133). To rescue an influenza virus in the unidirectional system, plasmids with the
human RNA polymerase I (Pol I) promoter and the hepatitis delta virus ribozyme
sequence or the mouse Pol I terminator are used to generate vRNA-like transcripts and
are cotransfected with four other helper plasmids expressing PB2, PB1, PA/P3, and NP
(128, 129, 131). In the bidirectional system, viral cDNA is inserted between the human
Pol I promoter and the murine Pol I terminator, and the entire Pol I transcription unit is
flanked by the bovine growth hormone (BGH) polyadenylation site or the simian virus 40
(SV40) late mRNA polyadenylation signal and the cytomegalovirus (CMV) Pol II
promoter (123, 130, 133). Plasmids with the Pol I-Pol II transcription units allow the
generation of both vRNA and mRNA from one viral cDNA template via the two different
orientations. A modified system has been made to reduce the number of plasmids
required for virus generation. This system combines multiple Pol I transcription units on
one plasmid and allows the efficient generation of IAV in Vero cells (126). Finally, to
overcome the limitation of species specificity of the Pol I transcription system, a T7 RNA
polymerase-driven reverse-genetics system (RGS) was developed for efficient rescue of
influenza viruses in human, avian, and canine cells (132).
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Here, we describe the first RGS for IDV. By using a bidirectional seven-plasmid-based
system, we generated recombinant influenza D/swine/Oklahoma/1314/2011 (D/OK)
viruses. Their biological characteristics were evaluated in detail, and our analyses showed
that RGS-rescued viruses had replication and receptor-binding properties similar to those
of wild-type viruses in cell culture. We also developed a minigenome replication assay
for IDV. This assay was successfully used to identify determinants of the activity of the
IDV RNP complex essential for viral replication. In summary, we have successfully
developed a minigenome replication assay and reverse-genetics system, and these tools
can be used to further investigate the biology, tissue tropism, and transmission of IDV.

3.2 Results

3.2.1 Generation of infectious influenza D/swine/Oklahoma/1314/2011 virus by the
reverse-genetics system

The cDNAs of the seven genomic segments (PB2, PB1, P3, HEF, NP, M, and NS) of
influenza virus D/swine/Oklahoma/1314/2011 (D/OK) were amplified by reverse
transcription-PCR (RT-PCR) and cloned individually into the bidirectional vector
pHW2000 (Figure 3-1A). The pHW2000 vector contains the human Pol I promoter and
the murine Pol I terminator that direct the precise synthesis of vRNA from one strand,
flanked by the truncated CMV promoter and the BGH poly(A) signal that direct viral
mRNA transcription from the opposite strand (123) (Figure 3-1A). The seven plasmids
encoding each of the genomic segments of D/OK virus were cotransfected into
cocultured HEK-293T (293T)–Madin-Darby canine kidney (MDCK) cells. Five days
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after transfection, supernatants were collected and inoculated onto fresh MDCK cells.
Three to five days after inoculation, infectious virus was detected only when all seven
plasmids were present (data not shown). No virus was detected in the control group in
which the plasmid encoding the PB2 segment was excluded. These results indicated that
the infectious virus was generated from cloned plasmids following transfection.

Figure 3-1. Generation of infectious influenza D/swine/Oklahoma/1314/2011 virus by the
reverse-genetics system. (A) Schematic representation of the bidirectional seven-plasmid-based
reverse-genetics system for IDV. The seven IDV cDNA segments were cloned into the pHW2000
vector (123). Each of the cDNA segments was flanked by the human Pol I promoter and the
murine terminator. The RNA Pol I transcription unit was flanked by the truncated CMV promoter
and the bovine growth hormone (BGH) poly(A) signal. (B and C) Growth kinetics of the wild-
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type D/OK and the rescued D/OK-RGS viruses. MDCK cells were infected with the D/OK or
D/OK-RGS virus at a MOI of 0.1 (B) or an MOI of 0.01 (C). Samples of supernatants were
collected at the indicated times, and virus titers were then determined in MDCK cells by a
TCID50 assay. The data presented in panels B and C are representative of results from three
independent experiments, with each experiment analyzing samples in duplicate.

To determine whether there is any difference in replication between wild-type D/OK
virus and rescued D/OK-RGS virus, we studied the growth kinetics of these viruses in
MDCK cells. The cells were infected with the viruses at multiplicities of infection (MOIs)
of 0.1 and 0.01. Samples of supernatants were collected every 24 h from day 0 to day 6,
and virus titers were then determined by a 50% tissue culture infective dose (TCID50)
assay. The wild-type D/OK virus and the rescued D/OK-RGS virus showed similar
growth kinetics in MDCK cells infected at a MOI of 0.1 (Figure 3-1B) or a MOI of 0.01
(Figure 3-1C). Taken together, these data led us to conclude that the influenza D/OK
virus was successfully rescued by the reverse-genetics system presented here.

3.2.2 Replication kinetics of continuously passaged influenza D/OK-RGS viruses at
different temperatures

To ensure that rescued viruses from the transient transfection of 293T-MDCK cell
cocultures with IDV RGS plasmids are stable in terms of infectivity during the course of
serial passages, we conducted five more passages in MDCK cells using the RGS-derived
virus and then analyzed their infectivity using the TCID50 assay. As shown in Figure 32A, similar virus stock titers were observed for D/OK-RGS viruses from passage 1 (P1)
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to P5, ranging from 5.62 x104 TCID50/ml to 3.80 x 105 TCID50/ml. This result indicates
that viruses rescued from our IDV RGS are stable and that the developed genetic system
can be further exploited to study IDV infection biology.

Figure 3-2. Growth kinetics of continuously passaged influenza D/OK-RGS viruses at different
temperatures. (A) MDCK cells were infected with D/OK-RGS virus at an MOI of 0.01. After 5
days of infection, culture supernatants were collected and used for the next passage in MDCK
cells. Virus titers at the indicated passages were determined by a TCID50 assay. (B and C)
MDCK cells were infected with different passages of D/OK-RGS virus at an MOI of 0.01,
followed by further incubation at 37°C (B) or 33°C (C). Samples of supernatants were collected
at the indicated days and then titrated by a TCID50 assay. The data presented are representative
of results from three independent experiments, with each experiment analyzing samples in
duplicate.

Influenza D virus differs substantially from the related human influenza C virus (ICV) in
temperature-restricted replication. Specifically, IDV replication is permissive at both
33°C and 37°C, while ICV replication is largely restricted to 33°C. Next, we determined
whether RGS-derived viruses replicated in the same manner as the parental virus at both
temperatures. As summarized in Figure 3-2B and C, different passages of D/OK-RGS
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viruses (P2 to P5) replicated efficiently at both 33°C and 37°C, although the overall
replication efficiency of these viruses was slightly lower at 33°C than at 37°C (Figure 23B and C). Furthermore, the serially passaged D/OK-RGS viruses showed similar growth
kinetics at either 33°C or 37°C (Figure 3-2B and C). These data collectively show that
IDV RGS-derived viruses, similar to the parental virus, replicate efficiently at both 33°C
and 37°C, which further supports the utility of IDV RGS in future mechanistic studies
toward elucidating a genetic basis of the temperature-mediated restriction that separates
IDV from its related ICV.

3.2.3 Receptor binding of the wild-type D/OK and rescued D/OK-RGS viruses

Viral attachment to receptors on the host cell surface is the initial step of the virus life
cycle. Sialic acids (SAs) have been found to serve as receptors for influenza viruses. Nacetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc) are the most
common SAs found on mammalian cell surfaces, both of which are ligands for influenza
viruses. SAs are generally attached to glycan chains on glycoproteins or glycolipids via
different glycosidic linkages. The most frequent linkage types are α-2,3 and α-2,6 linked
to a galactose residue. IAV and IBV recognize α-2,3- or α-2,6-linked sialic acid moieties
as receptors (8). However, ICV utilizes N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2),
which has an additional O-acetyl group at the C-9 position as the receptor; this is
independent of the α-2,3- or α-2,6-linkage to the following galactosyl residue (20). A
recent study shows that the IDV HEF protein can bind both Neu5,9Ac2 and 9-O-acetylN-glycolylneuraminic acid (Neu5Gc9Ac), regardless the α-2,3- or α-2,6-linkage, which
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indicates that IDV uses 9-O-Ac-SAs as its receptor (29). The chemical structures of these
SAs are shown in Figure 3-3A.

Figure 3-3. Receptor-binding properties of the wild-type D/OK virus and the recombinant D/OKRGS virus. (A) Chemical structures of sialic acids that serve as receptors for influenza viruses. (B
and C) Inhibition of viral hemagglutination by receptor analogs. The receptor analog Neu5,9Ac2
(B) or Neu5Gc9Ac (C) at the indicated concentrations was added to the virus containing 4 HA
units. Mixtures were incubated for 30 min at room temperature. Aliquots of turkey RBCs were
then added to the mixtures, and results were read after 30 min at room temperature. PBS was used
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as a negative control. Note that “-” indicates no hemagglutination, while “+” denotes evident
hemagglutination. The data presented in panels B and C are representative of results from four
independent experiments, with each experiment analyzing samples in duplicate.

To further investigate whether the RGS-derived IDV resembles the parental virus in its
receptor-binding profile, we used the traditional hemagglutination (HA) assay-based
competitive inhibition approach to determine their receptor-binding properties, replacing
antibody with synthetic receptor analogs. The viruses were incubated with the receptor
analogs at various concentrations ranging from 0 to 1,024 ng/µl. Both D/OK and D/OKRGS viruses were capable of agglutinating turkey red blood cells (RBCs) in the presence
of lower concentrations of receptor analogs (Figure 3-3B and C). However, the HA
activity of both viruses was completely inhibited in the presence of Neu5,9Ac2 at
concentrations of 128 ng/µl and above (Figure 3-3B) or in the presence of Neu5Gc9Ac at
a concentration of 512 ng/µl (Figure 3-3C). Because the nonspecific reaction
(agglutination) occurred between RBCs and higher concentrations of Neu5Gc9Ac, no
HA inhibition was observed for both viruses in the presence of 1,204 ng/µl Neu5Gc9Ac
(Figure 3-3C). In summary, the results suggested that the wild-type D/OK and rescued
D/OK-RGS viruses had the same capacity to interact with the sialic acid receptors
Neu5,9Ac2 and Neu5Gc9Ac. The data presented here are important, as they further
confirm the utility of our reported IDV RGS in future studies toward illustrating the
molecular and chemical details of IDV receptor binding and entry.
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3.2.4 Activity of the IDV RNP complex with PB1-E697K or PB2-L462F mutation

During the course of IDV RGS development, we identified two key mutations (PB1E697K and PB2-L462F) that prevented us from successfully rescuing infectious virus
particles. These two mutations were likely introduced by reverse transcription or PCR.
These mutations have not been observed in natural IDV isolates. Here, we took
advantage of these two coincident mutations and used them to assess the robustness of
the newly developed IDV RGS. As demonstrated in Figure 4-4B, we found that the PB1E697K mutation caused attenuation of viral replication, while the PB2-L462F mutation
rendered the virus replication incompetent. To find out the underlying mechanisms, we
developed a minigenome replication assay to investigate whether the PB1-E697K or
PB2-L462F mutation directly affects the activity of the IDV RNP complex. We
synthesized a reporter plasmid, pUC57mini-D/OK-HEF-Reporter, that contains the green
fluorescent protein (GFP) reporter gene located between the 5’- and 3’-end sequences of
the viral cRNA of the D/OK HEF segment and flanked by the Pol I terminator and the
human RNA Pol I promoter (Figure 4-4A). This reporter plasmid was cotransfected with
plasmids encoding PB2, PB1, P3, and NP into 293T cells. The cellular RNA Pol I bound
to the Pol I promoter to produce a reporter transcript that mimics the HEF vRNA, and the
incoming viral polymerase complex then recognized the HEF terminal regions (viral
promoter sequence) on the reporter transcript, initiating mRNA production for the
expression of the GFP reporter. The GFP reporter was qualitatively detected by
fluorescence microscopy (Figure 4-4C), while its expression level was quantitatively
analyzed by both Western blotting (Figure 4-4D) and fluorescence-activated cell sorter
(FACS) analysis (Figure 4-4E).
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Figure 3-4. Legend in the next page
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Figure 3-4. Activity of the IDV RNP complex with the PB1-E697K or PB2-L462F mutation. (A)
Schematic diagram of the pUC57mini-D/OK-HEF-Reporter plasmid. This reporter plasmid
contains the GFP reporter gene inserted between the D/OK-HEF cRNA 5= and 3= ends and then
flanked by the Pol I terminator and the human RNA Pol I promoter. All ATG codons before the
GFP translation initiation codon in the construct were mutated to CTGs; thus, the translation of
GFP utilized its own start codon. (B) Virus titers for PB1-E697K and PB2-L462F mutants were
determined by a TCID50 assay. Note that IDV OK-RGS660-PB1 is identical to IDV OK-RGS
except for the PB1 segment derived from IDV D/660. (C to E) Activity of the IDV wild-type
RNP complex or the RNP complex with the PB1-E697K or PB2-L462F mutation was measured
by a minigenome replication assay. In this assay, the GFP reporter plasmid and the wild-type or
mutant plasmids encoding IDV RNP complex components were cotransfected into HEK-293T
cells. At 48h post-transfection, cells were collected, and the GFP reporter was detected and
analyzed by fluorescence microscopy (C), Western blotting (D), and FACS analysis (E). NP or βactin was also detected by Western blotting, which was set up as a transfection or loading control,
respectively. Note that densitometry of Western blot bands was quantified by using ImageJ
software (https://imagej.nih.gov/ij/). Specifically, the density of the GFP band (i.e., surrogate of
viral RNP activity) was first normalized by the value obtained with the input transfected NP
control (i.e., to gauge the transfection variability). Relative viral RNP activity was determined by
setting the level of the wild-type “OK-RNP” group to 1.00. (F) Mutations PB1-E697K and PB2L462F are localized on the complex structure of RNA polymerase from ICV (PDB accession
number 5D98). The structure of RNA polymerase was downloaded from the PDB
(https://www.rcsb.org/) and was shown in PyMOL. The data presented in panels B to E are
representative of results from three independent experiments, with each experiment analyzing
samples in duplicate. eGFP, enhanced GFP.
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We analyzed the activity of the IDV RNP complex with the PB2-L462F or PB1-E697K
mutation by using the minigenome replication assay. Interestingly, no green fluorescence
was observed when wild-type PB2 was replaced by the mutated PB2-L462F segment
(Figure 4-4C). In support of this observation, the expression of GFP was below the
detection level as either measured by Western blotting (Fig. 4D) or quantified by FACS
analysis (Figure 4-4E). These results indicated that the L462F mutation on PB2 severely
abolished the activity of the IDV RNP complex. For the PB1-E697K mutation that was
observed only in the influenza virus D/bovine/Oklahoma/660/2013 (D/660) PB1 segment
during our initial effort in the development of the IDV RGS, we first determined whether
the wild-type D/660 PB1 segment could replace its counterpart (D/OK PB1) in the
minigenome replicon assay. As demonstrated in Figure 4-4C to E, the substitution had no
detectable effect on D/OK RNP activity. Interestingly, the RNP activity, as indicated by
GFP reporter levels, was significantly decreased when wild-type D/OK PB1 was replaced
with the mutant D/660 PB1-E697K segment (Figure 4-4C to E), indicating an essential
role of PB1 E697 in viral genome replication of IDV. In summary, the PB2-L462F and
PB1-E697K mutations, encountered during initial IDV RGS development, can lead to
either replication-incompetent or replication-attenuated virus, likely caused by their direct
effect on the activity of the IDV RNP complex.

To further investigate the underlying mechanisms by which PB1-E697K and PB2-L462F
mutations impair RNP complex activity, we took advantage of the recently resolved
structure of the RNA polymerase complex from ICV (PDB accession number 5D98) in
the absence of promoter RNA (134) to structurally visualize the location of these two
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mutations. Since the PB1 and PB2 proteins show high sequence similarity between ICV
and IDV (4), and the corresponding positions are absolutely conserved in ICV, we
assumed that the IDV RNA polymerase complex could adopt a structure similar to that of
ICV and that structural modeling could offer mechanistic insight into mutation-associated
replication defects. Our analysis showed that PB1 E697 most likely binds PB2 through
hydrogen bonding to PB2 K207 (3.1 Å between E697 OE1 and K207 NZ atoms) and also
forms an anion-pi interaction with PB2 F175 (~3.6 Å between E697 OE1 and F175 CZ
atoms) (Figure 4-4F). The PB1-E697K mutation likely disrupts such interactions. PB2
L462 is located at the hydrophobic region of the cap-binding domain of PB2; thus, the
PB2-L462F mutation may alter the stability or the conformation of the domain (Figure 44F). However, such interpretations should be taken cautiously because the structural
resolution of the ICV RNP complex is relatively suboptimal (around 3.9 Å), and the sidechain locations may be inaccurate. Further structure-function studies of IDV RNP will
test these hypotheses.

3.2.5 Recognition and transcription of the heterotypic promoter sequence by the
IDV polymerase complex

Our previous work showed that the 1-nucleotide difference observed in the conserved 3’
noncoding ends of the vRNA segments between IDV and ICV could contribute to the
failure of functional reassortment between these two viruses (4). It should be noted that in
addition to this polymorphism at position 5 within the 3’ noncoding sequences, the
noncoding regions (NCRs) across the seven segments between IDV and ICV are
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relatively variable in both sequence and length, especially after the first 11 to 12
nucleotides (Figure 3-5A). These sequence variations as a whole may have a negative
impact on the efficient cross-recognition of a heterotypic promoter by the viral RNP
complex, resulting in the inhibition of vRNA replication and limiting functional
reassortment between IDV and ICV (21). As a first step to address this hypothesis, we
sought to determine whether the single polymorphism at position 5 between IDV and
ICV affected the inefficient cross-recognition of the heterotypic promoter by the viral
RNP complex. In this regard, we analyzed the activities of viral RNP complexes when
cognate and noncognate promoters were provided in the minigenome replication assay.

Similar to the generation of the HEF segment-based GFP reporter plasmid, we
constructed D/OK and influenza virus C/Victoria/2/2012 (C/Vic) M segment-based GFP
reporter plasmids in which the full-length 5’ and 3’ noncoding regions of both M
segments (containing both conserved and variable sequences) were used to direct the
expression of the GFP reporter (Figure 5-5A). HEK-293T cells were cotransfected with
plasmids expressing the RNP complex components from either D/OK or C/Vic and a
reporter plasmid that contains the 5’ and 3’ noncoding regions of the M segment from
one of the two viruses. According to the fluorescence microscopy and Western blot
results, the D/OK RNP complex (D-RNP) or the C/Vic RNP complex (C-RNP) initiated
the expression of GFP not only from its cognate reporter but also from the noncognate
reporter (Figure 3-5B and C). However, the expression levels were visibly different
between the cognate and noncognate groups, which showed that D-RNP with the cognate
reporter or C-RNP with the cognate reporter produced higher levels of GFP than D-RNP
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with the ICV reporter or C-RNP with the IDV reporter, respectively (Figure 3-5B and C).
To further confirm these results, we quantified GFP expression by FACS analysis. There
were 39.4% GFP-positive cells in the D-RNP-plus-IDV reporter group but only 22.4%
GFP-positive cells in the D-RNP-plus-ICV reporter group (Figure 3-5D). Similarly, CRNP working with the ICV reporter generated 34.9% of the positive GFP expression,
while C-RNP working with the IDV reporter generated only 19.7% of the positive GFP
expression (Figure 3-5D). These results indicated that IDV RNP or ICV RNP preferred
using its cognate promoter to express proteins.

Figure 3-5. Activities of IDV and ICV RNP complexes with the conserved cognate or
noncognate noncoding ends of vRNA segments. (A) Diagram showing nucleotide sequences of
both the 3’ and 5’ noncoding regions in the M segment of influenza C and D viruses within the
context of the GFP-based reporter. Note that the fifth nucleotide of the 3’ noncoding end is
different between the M segment sequences of influenza C and D viruses and is in red with
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boldface type. “D(A-C)” indicates a mutated IDV reporter in which the fifth nucleotide, A, on the
3’ noncoding end of the D/OK M segment is altered to C, which makes it like the C/Vic M
segment 3’ NCR in the first 11 nucleotides. (B to D) Activities of IDV and ICV RNP complexes
with the cognate or noncognate promoter were determined by the minigenome replication assay.
HEK-293T cells were cotransfected with the ICV or IDV M segment promoter sequence-based
GFP reporter plasmid and the plasmids expressing RNP complex components from either D/OK
or C/Vic. At 48 h posttransfection, cells were collected, and GFP reporter protein expression was
analyzed by fluorescence microscopy (B), Western blotting (C), and FACS analysis (D). Renilla
luciferase or β-actin detected by Western blotting was set up as a transfection or loading control.
Note that densitometry of Western blot bands was quantified by using ImageJ software
(https://imagej.nih.gov/ij/) (C). Specifically, the density of the GFP band (i.e., surrogate of viral
RNP activity) was first normalized by the value obtained with the input transfected Renilla
luciferase control (i.e., to gauge the transfection variability). Relative viral RNP activity was
determined by setting the level of the wild-type group involving C-RNP/C-reporter or D-RNP/Dreporter (containing the respective cognate promoter) to 1.00. The data presented in panels B to D
are representative of results from three independent experiments, with each experiment analyzing
samples in duplicate.

Since there is only one difference in the first 11 nucleotides of the 3’ NCR between IDV
and ICV (4, 21) (Table 3-2), it is very likely that this nucleotide difference affects
recognition and transcription of the heterotypic model GFP vRNA by the IDV or ICV
polymerase complex. To address this hypothesis, we constructed a mutated IDV reporter
plasmid in which the fifth nucleotide, A, on the 3’ NCR of the D/OK M segment was
altered to C, which made it like the ICV M segment 3’ NCR in the first 11 nucleotides
(Figure 3-5A). It should be noted that the first 11 nucleotides are absolutely conserved in
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the 5’ NCR of the M segment between IDV and ICV. Interestingly, this substitution gave
rise to significant increases in the expression and replication of the mutant IDV reporter
by C-RNP compared to those observed for the wild-type IDV reporter with heterotypic
C-RNP in the minireplicon assay (27% versus 19% GFP-positive cells) (Figure 3-5B and
D). Conversely, the substitution reduced substantially the activity of the IDV reporter by
its cognate D-RNP in comparison to that observed in the minireplicon assay involving the
wild-type IDV reporter and D-RNP (22% versus 39.4% GFP-positive cells) (Figure 3-5B
and D). Quantitative analysis of GFP expression levels in Western blot assays using
ImageJ (https://imagej.nih.gov/ij/) also confirmed the differential activity observed in the
cell-based minireplicon assay (Figure 3-5C). For example, the GFP expression level from
C-RNP/mutant D reporter containing an A-to-C substitution increased by more than 2fold compared to that shown from the combination of C-RNP/D reporter. In contrast, the
GFP expression level decreased by approximately 3-fold for the D-RNP group when the
same mutant D reporter was provided in transfected cells. Altogether, these results
revealed that the 1-nucleotide change in the highly conserved noncoding region
negatively influences the heterotypic recognition and transcription of vRNAs by the viral
RNP complex. The observed heterotypic promoter incompatibility together with other
viral factors, such as packaging sequence variation, may contribute to the failure of viable
reassortment between IDV and the closely related ICV, which warrants further
investigation.
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3.3 Discussion

Reverse-genetics systems (RGSs) have already been described for IAV, IBV, and ICV
but not yet for IDV. In this study, the first RGS of IDV was successfully developed using
a bidirectional seven-plasmid-based system, and the resultant viruses were studied in
comparison with the wild-type viruses. We also developed a minigenome replication
assay

for

IDV.

Biological

characterizations

involving

mutations

collectively

demonstrated the robustness and versatility of these two systems, indicating their utility
as powerful tools to study structure-function relationships of IDV proteins. The IDV RGS
can also be used to elucidate critical determinants that drive IDV to use this agricultural
animal as a primary reservoir and amplification host.

Many different ways have been established in the past 2 decades to generate recombinant
influenza viruses, including earlier helper virus-dependent methods and later helper
virus-independent plasmid-based systems. In helper virus-dependent methods, selection
strategies are required because additional helper viruses are used and therefore have to be
depleted through drug selection. Owing to this disadvantage, helper virus-dependent
methods have been largely replaced by later helper virus-independent plasmid-based
methods (127). The unidirectional and bidirectional plasmid-based systems have emerged
as two predominant helper virus-independent RGSs, which have been previously reported
for IAV, IBV, and ICV (123, 125, 128-131, 133). In the present study, we succeeded in
rescuing recombinant IDVs by using a bidirectional seven-plasmid-based system (Figure
3-1), which is the first RGS reported for IDV. Generally, it is difficult to compare the
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generation efficiencies and titers of different influenza virus RGSs. Many factors, such as
the cell line selected, transfection efficiency, technical protocol, and virus replication
fitness, may determine which strategy should be used. Initially, we failed to generate the
recombinant D/OK virus when we directly followed protocols (123) that are commonly
used for the rescue of influenza A viruses. We realized that the D/OK virus cannot induce
significant cytopathic effects and has a much lower replication capacity than influenza A
virus in MDCK cells. Moreover, the 293T cell line has weak adhesion to the surfaces of
cell culture vessels and is extremely sensitive to tosylsulfonyl phenylalanyl chloromethyl
ketone (TPCK)-trypsin, which is required for the cleavage of the HEF protein and
probably activation of viral fusion. Therefore, we added a lower concentration of TPCKtrypsin at a later time point, which was optimal to maintain 293T cell viability and, as a
result, provided sufficient time for rescue of the recombinant D/OK virus. After making
these subtle but critical changes, we could detect the rescued D/OK virus in the
supernatant of transfected 293T-MDCK cells at 4 to 5 days posttransfection, which was
slower than the rescue of influenza A virus, which could be detected at 2 to 3 days
posttransfection (123). These findings suggest that rescue strategies for different types or
strains of influenza virus should be adjusted according to their replication property and
fitness, which will be vital for the successful rescue of IDV or IDV-similar influenza
viruses.

Our comparative in vitro growth kinetics studies showed indistinguishable replication
fitness of both the parental and RGS-derived viruses, and the RGS viruses can be stably
cultured over multiple passages, at both 33°C and 37°C (Figure 3-1 and 2). In addition,
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the RGS viruses displayed a receptor-binding capacity indistinguishable from that
displayed by the authentic virus (Figure 3-3). These studies clearly suggested that an
efficient reverse-genetics system was successfully established and allowed for the genetic
manipulation of viral genomes and the generation of mutant viruses, which opens the
door for studying the functional importance of viral proteins and molecular aspects of
viral replication and pathogenicity.

It has been known that both IDV and ICV contain only one major surface glycoprotein,
HEF, which plays multiple critical roles during the virus life cycle (4, 20). First, HEF
binds to the receptor to initiate virus entry. In agreement with previous reports (29), our
results showed that IDV HEF could recognize both Neu5,9Ac2 and Neu5Gc9Ac (Figure
3-3), which is different from ICV HEF, which prefers Neu5,9Ac2 over Neu5Gc9Ac as a
viral receptor (20). HEFs of ICV and IDV have about 53% homology and possess almost
identical overall structures (28). One interesting difference between them is that the IDV
HEF protein has an open channel in the receptor-binding region, while in the structurally
identical region of ICV HEF, there is a salt bridge (29). This subtle difference may
indicate that IDV has different receptor-binding properties compared to ICV. With the
availability of the RGSs, we can directly investigate the diverse receptor-binding
properties arising from the subtle genetic differences between IDV and ICV. Second,
HEF was a critical determinant of IDV’s antigenic diversity. Amino acid substitutions
near the HEF receptor-binding region are involved in antigenic variation of influenza
viruses (135). To understand the molecular basis for IDV lineage-dependent antigenicity,
we can use the RGS to introduce select amino acid changes individually or in
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combination into the IDV HEF protein and analyze the antigenic properties of these
recombinant viruses to identify amino acids determining the antigenicity of IDV. Third,
HEF exhibits unique thermodynamic properties. It is known that ICV grows more
efficiently at 33°C than at 37°C (20, 136). HEF is considered to be an important
restriction factor for the temperature sensitivity of ICV (136). Interestingly, IDV
replicates well at both 33°C and 37°C (4) (Figure 3-2). Our previous experiments showed
that IDV was able to tolerate a high-temperature environment, and HEF is the primary
determinant for the high thermal stability of IDV (91). It will be very interesting to use
the RGS to determine the amino acids or protein motifs that account for the different
thermodynamic properties between ICV HEF and IDV HEF.

During the development of the IDV RGS, we identified several mutations in the viral
polymerase complex proteins that rendered the RGS less productive and led to the failed
rescue of viable viruses. To investigate the biological significance of these mutations and
gain mechanistic insight, we developed a minigenome replication assay for IDV. This
system has been widely used to study influenza virus RNP activity by cotransfecting cells
with four plasmids encoding PB2, PB1, PA/P3, and NP and a viral promoter-driven
reporter plasmid (128, 137). Our results of the minigenome replication assay showed that
the RNP activity was lost due to the introduction of the L462F mutation into D/OK PB2
(Figure 3-4), which explained why the PB2-L462F mutation caused the failure of RGS in
rescuing viruses. The E697K change in PB1 resulted in significantly lower RNP activity
than for wild-type PB1 (Figure 3-4). This finding was consistent with the observation that
the recombinant IDV containing the PB1-E697K mutation had an extremely low virus
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titer (Figure 3-4B). These two mutations on the polymerase complex proteins showed a
significant negative impact on RNP activity and, as a result, posed a challenge in rescuing
viable IDVs. These data also provide additional justification for exploring conserved
polymerase function as a target for anti-influenza drug development.

By using the minigenome replication assay, we further demonstrated that a single
nucleotide difference at position 5 of the 3’ NCR within the first 11 nucleotides between
IDV and ICV resulted in the inefficient cross-recognition of the heterotypic promoter by
the viral RNP complex. This functional incompatibility in vRNA replication between
IDV and ICV may contribute to the failure of viable reassortment between IDV and ICV,
as demonstrated in our previous study. In addition to this single polymorphism, the 3’
NCR also shows considerable sequence variation between IDV and ICV in the region
toward the segment-specific protein-coding sequence. Their impact on constraining IDV
and ICV reassortment should be further investigated. Because productive packaging of
vRNAs and successful reassortment between influenza viruses require multiple cis-acting
elements and trans-acting factors (138-140), we suppose that multiple factors are
probably involved in collectively restricting productive reassortment between IDV and
the closely related ICV in animal hosts. This hypothesis can be addressed using the
robust IDV RGS presented in this study.
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3.4 Materials and methods

3.4.1 Cells, viruses, and antibodies

Human embryonic kidney HEK-293T cells (ATCC) and Madin-Darby canine kidney
(MDCK) cells (ATCC) were maintained in Dulbecco’s modified Eagle medium (DMEM;
Gibco, Invitrogen, USA) supplemented with 10% (vol/vol) fetal bovine serum (FBS;
PAA Laboratories, Dartmouth, MA, USA) and 100 U/ml penicillin-streptomycin (Life
Technologies, Carlsbad, CA, USA). All cells were cultured at 37°C in the presence of 5%
CO2.

Influenza

viruses

D/swine/Oklahoma/1314/2011

(D/OK)

and

D/bovine/Oklahoma/660/2013 (D/660) were propagated in MDCK cells at 37°C.
Influenza virus C/Victoria/2/2012 (C/Vic) was grown in MDCK cells at 33°C. Polyclonal
rabbit antibody against IDV D/OK was generated in-house by immunizing rabbits with
concentrated IDV particles that were inactivated by UV light treatment. Polyclonal rabbit
anti-GFP antibody was obtained from Santa Cruz Biotechnology, while monoclonal antiβ-actin antibody was purchased from Sigma-Aldrich. Secondary antibodies such as
IRDye 680RD donkey anti-rabbit IgG and IRDye 680RD goat anti-mouse IgG were
purchased from Li-Cor.

3.4.2 Construction of plasmids

Viral RNAs were isolated from infectious virus particles with the TRIzol LS reagent
(Invitrogen, CA, USA) according to the manufacturer’s instructions. RT-PCR was
performed with a high-capacity cDNA reverse transcription kit (Thermo Fisher Scientific)
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according to the protocol provided by the manufacturer. The primers used to amplify
each individual segment in the RT-PCRs are summarized in Table 3-1. After digestion of
the PCR products with BsmBI or BsaI, the fragments were purified and cloned into the
pHW2000 vector (123) (Fig. 3-1A). All inserted cDNAs were sequenced and confirmed
(GenScript, NJ, USA) to ensure that there were no unwanted mutations in the constructs.

3.4.3 Transfection and rescue of recombinant viruses

Approximately 20 to 24 h before transfection, cells (~6 x 105 HEK-293T cells and ~1.5 x
105 MDCK cells) were plated in 2 ml of complete growth medium per well in a 6-well
plate. Prior to transfection, cells were 50% to 70% confluent, and the old growth medium
was replaced with fresh medium containing 10% FBS without antibiotics. The reversegenetics plasmids of IDV (1 µg for each segment) were mixed and added into 200 µl of
Opti-MEM. Next, 18 µl of polyethylenimine (PEI) was dropped into the premixed diluted
plasmids. Mixtures were incubated for 20 min at room temperature and added into
different areas of the wells. The culture vessel was gently rocked back and forth and from
side to side to evenly distribute the DNA-PEI complexes. At 6 to 9 h posttransfection, the
old medium was replaced with 2 ml of fresh DMEM without FBS but containing
antibiotics. After another 36 to 42 h of incubation at 37°C, 0.5 ml of DMEM containing 1
µg/ml TPCK-trypsin (Thermo Fisher Scientific) was added to each well. Virus HA titers
of ~32 could be detected 3 to 5 days after transfection.
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3.4.4 Virus replication assay

Viruses were cultured and measured in MDCK cells in DMEM supplemented with 1
µg/ml TPCK-trypsin and 100 U/ml penicillin-streptomycin. Viral growth kinetics studies
were performed on a monolayer of MDCK cells using an inoculum at a multiplicity of
infection (MOI) of 0.1 or 0.01. One hour after incubation at 37°C, cells were washed
twice with phosphate-buffered saline (PBS), and fresh DMEM with 1 µg/ml TPCKtrypsin and 100 U/ml penicillin-streptomycin was added. Samples were collected at 0, 24,
48, 72, 96, 120, and 144 h postinfection and titrated by a TCID50 assay.

Table 3-1 Primers used in the RT-PCR and cloning experiments
Primer

Sequence (5’–3’)

PB2_IDV_BsaⅠ_For

TATTGGTCTCAGGGAAGCATAAGCAGAGGATGTCACTACTATTAAC

PB2_IDV_BsaⅠ_Rev

ATATGGTCTCGTATTAGCAGTAGCAAGAGGATTTTTTCAATG

PB1_IDV_BsmBⅠ_For

TATTCGTCTCAGGGAAGCATAAGCAGAGGATTTTATAAAATGG

PB1_IDV_BsmBⅠ_Rev

ATATCGTCTCGTATTAGCAGTAGCAAGAGGATTTTTCTGTT

P3_IDV_BsaⅠ_For

TATTGGTCTCAGGGAAGCATAAGCAGGAGATTTAGAAATGTCTAG

P3_IDV_BsaⅠ_Rev

ATATGGTCTCGTATTAGCAGTAGCAAGGAGATTTTTAACATTACAAG

HEF_IDV_BsmBⅠ_For

TATTCGTCTCAGGGAAGCATAAGCAGGAGATTTTCAAAGATG

HEF_IDV_BsmBⅠ_Rev

ATATCGTCTCGTATTAGCAGTAGCAAGGAGATTTTTTCTAAGATTC

NP_IDV_BsmBⅠ_For

TATTCGTCTCAGGGAAGCATAAGCAGGAGATTATTAAGCAATATGG

NP_IDV_BsmBⅠ_Rev

ATATCGTCTCGTATTAGCAGTAGCAAGGAGATTTTTTG

M_IDV_BsmBⅠ_For

TATTCGTCTCAGGGAAGCATAAGCAGAGGATATTTTTGACGCAATG

M_IDV_BsmBⅠ_Rev

ATATCGTCTCGTATTAGCAGTAGCAAGAGGATTTTTTCGC

NS_IDV_BsmBⅠ_For

TATTCGTCTCAGGGAAGCATAAGCAGGGGTGTACAATTTCAATATG

NS_IDV_BsmBⅠ_Rev

ATATCGTCTCGTATTAGCAGTAGCAAGGGGTTTTTTCATACTAAAG
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3.4.5 Hemagglutination-based competitive inhibition assay

Twenty-five microliters of virus suspensions containing 4 HA units of virus was added to
25 µl of receptor analogs (Neu5,9Ac2 or Neu5Gc9Ac) (Glycohub). The virus-receptor
analog mixtures were incubated for 30 min at room temperature. Fifty microliters of 1%
turkey red blood cells (RBCs) (Lampire Biological Laboratories, Pipersville, PA, USA)
was then added to the mixtures, and results were read after 30 min. PBS was used as a
negative control.

Table 3-2. Comparison of the conserved 3’-noncoding ends of the vRNA segments from
influenza C and D viruses

Segment

D/OK 3’ NC end (3’-5’orientation)

C/Vic 3’ NC end (3’-5’orientation)

PB2

UCGUAUUCGUCUCCUA

UCGUCUUCGUCUCCUA

PB1

UCGUAUUCGUCUCCUA

UCGUCUUCGUCUCCUA

P3

UCGUAUUCGUCCUCUA

UCGUCUUCGUCCCCUA

HEF

UCGUAUUCGUCCUCUA

UCGUCUUCGUCCCCUU

NP

UCGUAUUCGUCCUCUA

UCGUCUUCGUCCUCUA

M

UCGUAUUCGUCUCCUA

UCGUCUUCGUCCCCUA

NS

UCGUAUUCGUCCCCAC

UCGUCUUCGUCCCCAU

3.4.6 Minigenome replication assay

A reporter plasmid, pUC57mini-D/OK-HEF-Reporter, was synthesized by GenScript. It
contains the GFP reporter gene inserted between the 5’- and 3’-end sequences of the viral
cRNA of the D/OK HEF segment, and it is flanked by the Pol I terminator and the human
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RNA Pol I promoter (Figure 3-4A). All ATG codons before the GFP translation initiation
codon in the construct were mutated to CTGs; thus, the translation of GFP used its own
start codon (Figure 3-4A). The M segment promoter sequence-based GFP reporter
plasmids for both ICV and IDV were generated by conventional PCR and mutagenesis.
The reporter plasmid was cotransfected with plasmids expressing RNP complex
components (PB2, PB1, P3, and NP) into HEK-293T cells. At 48 h posttransfection, cells
were collected, and the GFP reporter protein was detected by fluorescence microscopy
and Western blotting. Percentages of GFP-positive cells were quantified by flow
cytometry.

3.4.7 Statistical analysis

The data presented in this paper are representative of results from three independent
experiments, with each experiment assaying samples in duplicate. Standard-deviation
bars indicate the variations among experiments. To analyze the difference between
groups, statistical analysis by one-way analysis of variance (ANOVA) followed by
Tukey’s multiple-comparison test was performed using GraphPad Prism 5.0. Statistically
significant differences are indicated in the figures (**, P < 0.01; ***, P < 0.001).

72

CHAPTER 4. IDENTIFICATION OF TWO RESIDUES WITHIN THE
NUCLEOPROTEIN THAT CRITICALLY AFFECT THE REPLICATION
FITNESS OF INFLUENZA D VIRUS
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4.1 Introduction

Influenza D virus (IDV), a new genus of the Orthomyxoviridae family, was first isolated
from clinical ill pigs in 2011 in Oklahoma, USA (4). Further epidemiological studies
demonstrated that cattle, not pigs, are the primary reservoir of this virus (21, 38, 40). To
date, IDV has been identified in many countries worldwide, including USA, Canada and
Mexico in North America; France, Italy, Ireland, Luxembourg and UK in Europe; China,
Japan and Turkey in Asia; and Morocco, Benin, Togo, Kenya and Ethiopia in Africa (4,
26, 40, 49-53, 62-64, 66-68). The high seroprevalence of IDV in cattle has been reported
in USA (77.5%, n=1992) (42), Japan (30.5%, n=1267) (66), France (42.7%, n=3326) (56),
Luxembourg (80.2%, n=450) (52), Italy (92.4%, n=420) (55), and Ireland (94.6%,
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n=1219) (57), respectively. The wide circulation and high prevalence of IDV, especially
in cattle, highlight the potential threat of IDV to other animal species. Indeed, IDV has
also been detected in small ruminants, horses, camels, buffaloes and feral pigs (23, 24, 26,
48, 54, 56, 57, 63, 68). These findings suggest that IDV has a global distribution with a
broad host range.

Several surveillance and metagenomic studies have shown that IDV detection rates are
higher in diseased cattle than that in healthy cattle, and the virus is highly associated with
bovine respiratory disease (BRD) complex (40, 43, 44, 63, 73). BRD is the most common
and costly disease in cattle industry. It is caused by complex interactions between host,
multiple pathogens including viruses and bacteria, and environmental factors, leading to
70-80% of the morbidity in USA cattle industry (43, 78). The pathogenesis of IDV in
cattle has also been validated by experimental infection studies. The results of these
studies revealed that IDV caused mild respiratory disease in cattle and could be
transmitted between cattle by direct contact or aerosol (74-77). In addition, IDV is able to
infect ferrets and guinea pigs, both surrogate models for studies of influenza viruses in
humans (4, 82). IDV infection causes little clinical symptoms but the virus can be
transmitted by direct contact in ferrets or guinea pigs (4, 82). Moreover, IDV has the
capacity to efficiently replicate in the well-differentiated human airway epithelial cells
(hAECs), frequently serving as an in vitro respiratory epithelium model for emerging
respiratory virus studies in humans (83, 84). These observations suggest that IDV may
have the potential to adapt and transmit to humans. Several serologic studies have
demonstrated that antibodies against IDV were detected in humans (4, 25, 61). Notably, a
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high seroprevalence of IDV was observed among workers with cattle exposure (34 out of
35 persons had IDV antibodies), as reported by a serological study in Florida, USA (25).
The prevalence of IDV-specific antibodies in humans implies that the virus may infect
humans.

Based on the sequences of the hemagglutinin-esterase-fusion (HEF) gene, IDV can be
classified into three genetic lineages: D/OK-lineage, D/660-lineage and D/Japan-lineage
(5). Recently, a new IDV strain isolated from Japan (D/bovine/Yamagata/1/2019) was
found to be genetically and antigenically distinguished from the described three lineages,
which may be represented as a new IDV lineage (71). The D/swine/Oklahoma/1334/2011
(D/OK), D/Bovine/Oklahoma/660/2013 (D/660) and D/bovine/Yamagata/10710/2016
(D/Yamagata) are the representative strains of the D/OK-, D/660-, and D/Japan-lineages,
respectively (5, 21, 38, 64). They are widely used for the phylogenetic and antigenic
studies of IDV. Both the common and lineage-specific antigenicity of IDV were observed
(5, 38). However, different molecular characteristics among these IDV lineages are not
known. The recent reported reverse genetics system of IDV (141, 142) should facilitate
our understanding of the molecular biology of this emerging influenza virus.

IDV, similar to influenza C virus (ICV), contains seven genome segments and encodes 9
proteins, including the polymerase subunits PB2, PB1, and P3, surface glycoprotein HEF,
nucleoprotein (NP), matrix protein M1, ion channel protein M2, and two nonstructural
proteins NS1, NS2 (4, 9, 22, 29, 143, 144). NP is a multi-functional protein in influenza
virus life cycle. As a critical component of ribonucleoprotein (RNP) complex, NP is
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essential for viral RNA transcription and replication (145). IDV NP contains a bipartite
nuclear localization signal (NLS) in the C-terminal tail, which interacts with importin-α7
to mediate nuclear import of NP (144). It is reported that some mutations in NP affect the
formation of NP homo-oligomers, interaction between polymerase subunits and the
binding to viral RNA, which are together associated with the RNP activity (146-148).
Furthermore, influenza A virus (IAV) NP can act as an elongation factor, while it is
dispensable for initiation and termination of viral RNA transcription and replication (149,
150). In addition, NP plays a important role in viral replication fitness through some other
mechanisms including immune evasion, regulation of apoptosis and autophagy, and
interactions with some other host factors (151-154).

In the present study, the different viral growth properties were observed and validated
between D/OK and D/660 viruses. By using a reverse-genetics system, we found that the
NP segment of IDV contributed to the viral replication fitness. Finally, our results
demonstrated that amino acids at the positions 247 and 381 of NP critically affected IDV
replication efficiency. Interestingly, these two amino acid changes in the NP do not affect
IDV RNP activity but may have effect on the late stage of the viral replication cycle,
which warrants further examination.

4.2 Results

4.2.1 The D/660 virus was superior to the D/OK virus in replication in different cell
lines
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To examine and compare the replication fitness of two lineage-representative IDV strains,
D/660 and D/OK, we first determined their replication kinetics in MDCK cells that are
commonly used for studies of influenza viruses. MDCK cells were infected in parallel
with either D/660 or D/OK at a MOI of 0.01 at 37 °C. Aliquots of the tissue culture
supernatant were taken at periodic intervals and analyzed for virus replication by using
the standard HA assay and TCID50 titration. The data showed that both viruses grew to
the peak viral titers at 3 days after infection (Figure 4-1A). Interestingly, we observed
that the D/660 virus had ~2.0 log10TCID50/ml or ~ 2.5 log2HA units, which were
substantially higher than the D/OK virus from 2 days post-infection in MDCK cells
(Figure 4-1A). The observed growth difference between two viruses was generally
maintained during the rest of this five-day experiment.

To confirm the observation, we further compared the replication kinetics of the two
viruses in other cell lines. The D/OK and D/660 viruses are respectively isolated from
swine and bovine, and able to replicate in a variety of cell lines including human cells (4,
21). Therefore, we performed comparisons of the replication abilities of the two viruses
in Swine Testis (ST) cells, Madin-Darby Bovine Kidney (MDBK) cells, and Human
Rectal Tumor (HRT-18) cells. The results of our experiments showed that the D/660
virus replicated to significantly higher titers than the D/OK virus in all these cell lines
(Figure 4-1B to D). The differences of peak viral titers between the D/660 and D/OK
viruses were ~2.5 log10TCID50/ml or ~ 3.0 log2HA units in ST cells (Figure 4-1B), ~2.0
log10TCID50/ml or ~ 3.5 log2HA units in MDBK cells (Figure 4-1C), and ~2.5
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log10TCID50/ml or ~ 3.5 log2HA units in HRT cells (Figure 4-1D). These data further
strengthened our observation that the D/660 virus was superior to the D/OK virus in
replication in multiple cell lines.

Figure legend in the next page.
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Figure 4-1. Replication kinetics of D/660 and D/OK viruses in different cell lines. (A-D) MDCK
(A), ST (B), MDBK (C) and HRT-18 (D) cell lines were inoculated with an 0.01 MOI of D/660
or D/OK viruses at the indicated time points. Virus titers were determined by TCID50 per ml in
MDCK cells and HA assay. The error bars are representative of three independent experiments.

4.2.2 NP was a key determinant of the replication difference between the D/660 and
D/OK viruses

To investigate the underlying mechanisms that attribute to the different viral replication
fitness between the D/660 and D/OK viruses, the reverse genetics system was employed
to generate chimeric viruses to examine which segment(s) affected the virus replication.
As shown in Figure 4-2A, the D/OK virus was used as a genetic backbone, and each of
the segment was replaced with its counterpart from the D/660 virus, respectively. MDCK
cells were infected with rescued wild-type D/OK virus and other chimeric viruses at a
MOI of 0.01, and culture supernatants were collected at the indicated time intervals and
assayed for virus replication by using the standard TCID50 experiment. Compared with
wild-type D/OK virus, none of the chimeric viruses carrying D/660 PB2, PB1, P3, M or
NS segment showed an improved growth kinetics (Figure 4-2B). However, in contrast to
the wild-type D/OK virus, when the HEF segment of the D/OK virus was replaced with
that of the D/660 virus, the titers of this recombinant virus increased by ~1
log10TCID50/ml (Figure 4-2B). Most importantly, if the NP segment was replaced, the
replication titers of the chimeric D/OK virus with the D/660 NP were 2 log10TCID50/ml
higher than that of the wild-type D/OK virus (Figure 4-2B). These results suggested that
the NP segment might play a critical role in determining the replication capacity of IDV.
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Figure 4-2. NP determines the replication difference between the D/660 and D/OK viruses. (A)
Schematic representation of wild-typed D/OK and seven chimeric viruses used in this study. Each
segment of D/OK virus was replaced with the corresponding D/660 viral segment, respectively.
All of the viruses were generated by RGS and tittered in MDCK cells at the same time. (B)
MDCK cells were infected with rescued D/OK or seven chimeric viruses with an MOI of 0.01. (C)
MDCK cells were infected with rescued D/OK virus, chimeric D/OK virus expressing D/660 PB1,
PB2 and P3 (D/OK-RGS660-pol) or chimeric D/OK virus expressing D/660 PB1, PB2, P3 and NP
(D/OK-RGS660-RNP). Viruses were titrated by TCID50 per ml in MDCK cells at the indicated days.
The error bars are representative of three independent experiments.
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As we know, recruitment of NP with viral RNA-dependent RNA polymerase leads to
form a RNP complex, which is critical for the viral transcription and replication. To
further investigate whether the polymerase subunits or RNP components work together to
contribute to the replication difference between the two virus strains, we rescued the
D/OK chimeric viruses carrying D/660 polymerase (PB2, PB1 and P3) or carrying the
four components of RNP complex (PB2, PB1, P3 and NP) from the D/660 virus strain.
We found that the D/OK chimeric virus carrying the D/660 polymerase grew at a rate
similar to the wild type D/OK virus, while if the RNP (polymerase plus the NP protein)
was replaced, the virus titer was significantly changed (2 log10TCID50/ml) (Figure 42C). These results further confirmed that NP is a key determinant of the replication
difference between the D/660 and D/OK viruses.

4.2.3 Two residues in positions 247 and 381 within the NP protein were key
determinants of the replication fitness of IDV

By alignment of NP protein seqeunces, five different amino acid residues, P74L, S132T,
E247D, K381E and A462T, were observed between the D/660 and D/OK viruses (Figure
4-3A). Structure studies indicated that NP formed a tetramer in solution (144). In the
structure modeling of the IDV NP, the residue 74 was close to the RNA binding groove,
the residue 132 was in the interior of the body domain, and the residue 381 was in the
body domain but outside of functional sites. The amino acids 247 and 462 were buried
and closed to the tetramer interface (Figure 4-3B).
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To explore which residue(s) within the IDV NP protein contribute to viral replication
fitness, the D/OK RGS was used to generate recombinant D/OK viruses with mutations
in NP protein. MDCK cells were infected with these mutant viruses at an MOI of 0.01,
and virus titers were measured by the TCID50 titration (Figure 4-3C). The virus with the
A462T or S132T mutation had little effect on viral growth property (Figure 4-3C).
However, the virus with E247D mutation replicated approximately 1 log10TCID50/ml
higher than the wild type D/OK virus. Importantly, the virus containing the NP-K381E
change displayed 2 log10TCID50/ml higher titers when compared to the wild-type D/OK
virus at the indicated time points, which possesses a replication kinetics similar to the
chimeric D/OK virus containing the D/660 NP (Figure 4-3C). These results suggested
that residues in position 247 and 381 of the NP were possible determinants for the
observed difference in replication kinetics between D/OK and D/660 viruses.

To confirm the critical roles of these two residues in IDV replication, loss-of-function
mutations were introduced into the D/660 NP segment. Compared to the chimeric D/OK
virus carrying the wild-type D/660 NP, viruses with mutant D/660 NP, D/660-NP-D247E
and D/660-NP-E381K replicated to 1 and 2 log10TCID50/ml lower titers, respectively
(Figure 4-4D). The replication levels of viruses carrying D/660 NP-L74P, T132S and
T462A mutations were similar to the virus containing wild-type D/660 NP segment
(Figure 4-4D). Taken together, our data demonstrated that the mutations in positions 247
and 381 of the NP protein attributed to the different replication properties between the
D/660 and D/OK viruses.
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Figure legend in the next page.
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Figure 4-3. Two residues in positions 247 and 381 within the NP protein were key determinants
of the replication fitness of IDV. (A) Alignment of the IDV NP protein. Five different amino acid
residues are identified between the D/OK and D660 virus strains, which are highlighted in the
above alignments. (B) Structural modeling of the IDV NP depicting cartoon and surface
representations. The four subunits of the NP tetramer are colored differently. The locations of 5
amino acid differences between D/OK virus and virus are noted by red color. (C) The chimeric
D/OK virus containing D/660 NP or four recombinant D/OK viruses each carrying a single-point
mutation (S132T, E247P, K381E and A462T) in NP were generated by RGS. (D) Single-point
mutant viruses (L74P, T132S, P247E, E381K and T462A) in NP were generated by using
chimeric D/OK virus containing D/660 NP as a backbone. MDCK cells were infected at MOI of
0.01 and the supernatants were harvested at the indicated days post infection and assayed for viral
infectivity by TCID50 experiment. The error bars represent the standard error of the mean of
three independent experiments.

4.2.4 Amino acid changes in NP had no effect on IDV RNP activity but might affect
virus replication in the late stage of the viral life cycle

As a critical component of RNP complex, NP provides a structural framework for viral
transcription and replication. Numerous publications reported that mutations in the NP
could affect the RNP activity by regulating its homo-oligomerization, viral RNA binding,
and polymerase assembly (146-148). To investigate the effects of NP mutations on the
RNP activity, minigenome replication assay was performed in HEK-293T cells, which
were co-transfected the GFP reporter plasmid with the plasmids expressing the
polymerase complex (PB2, PB1 and P3) and wild-type or mutant NP plasmids. The
percentage of positive cells expressing GFP (Figure 4-4A and 4B) was measured by

84

FACS. Unexpectedly, the percentage of GFP-positive cells was similar among groups
with the wild-type and mutant NP proteins (Figure 4-4A and 4B). Moreover, all the gainof-function mutations in D/OK-NP and loss-of-function mutations in D/660-NP had no
effect on GFP expression measured by Western-blot analysis in the mini-genome
replication assay (Figure 4-4C). The expression of NP and β-actin was set up as a
transfection or loading control. By quantifying the Western-blot bands, we found that the
ratios of GFP to NP (Figure 4-4D) and NP to β-actin (Figure 4-4E) were similar in the
indicated mutants. These data suggested that genetic variants of NP had no effect on IDV
RNP activity.

To further investigate the mechanisms of the NP that are responsible for the replication
fitness of IDV, droplet digital PCR (dd PCR) was performed to test if the NP affected
IDV replication in the early stage of its life cycle. MDCK cells were infected with the
D/OK or D/660 virus at the same MOI of 0.01. The infected cells were collected at
indicated time points, and the total mRNA was extracted for RT and dd PCR.
Interestingly, as shown in the Figure 4-4F, the relative viral mRNA copies of the D/OK
virus (with lower replication capacity) were significantly higher than that of the D/660
virus (with higher replication capacity) at the early stage (prior to 16 hours post-infection)
of the viral life cycle. Nevertheless, 16 hours after infection, the relative viral mRNA
copies of the D/660 virus dramatically increased while the relative viral mRNA copies of
the D/OK virus increased significantly lower than that of the D/660 virus (Figure 4-4F).
These results indicated that the amino acid changes in NP might affect IDV replication in
the late stage of the viral life cycle.
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Figure 4-4 continued

Figure 4-4. Amino acid changes in NP had no effect on IDV RNP activity but might affect virus
replication in the late stage of the viral life cycles. (A-C) Activity of the D/OK wild-type RNP
complex or the RNP complex with the indicated D/OK-NP or D/660-NP mutation was measured
by a minigenome replication assay. Briefly, Polymerase complex components derived from
D/OK virus together with their wild-type NP gene or mutant NP genes were co-transfected with
GFP reporter plasmid into HEK-293T cells. Fourth-eight hours later, GFP reporter protein
expression was estimated and analyzed by FACS analysis (A and B) and Western blotting (C).
NP and β-actin detected by Western blotting was set up as a transfection or loading control. (D
and E) The densitometry of Western blot bands was quantified by ImageJ software. The ratios of
GFP to NP (D) and NP to β-actin (E) were normalized by D/OK-RNP and set arbitrarily as 1. The
error bars are representative of three independent experiments. (E) Detection of relative viral
mRNA copies of IDVs by ddPCR in early stage. MDCK cells were infected with D/660 or D/OK
virus at an MOI of 0.01. Total RNAs were extracted at the indicated hours post-infection. The
mRNA level of viral segment NP was measured by ddPCR and presented as viral mRNA copies
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per 1000 TBP copies. The mRNA level of TBP was detected as an internal control. The error bars
are means and SD from three independent experiments. Statistical analysis was performed by
Student’s t test. *, P<0.05; ***, P<0.001.

4.3 Discussion

Here we observed replication differences between the two lineage-representative IDV
strains, D/660 and D/OK, in different cell lines. Specifically, using chimeric viruses
generated by RGS, we demonstrate that NP segment determined the replication fitness of
IDV. Furthermore, we identified that positions 247 and 381 within the NP protein
critically affect IDV replication in late stage of the viral life cycle.

As intracellular pathogens, influenza viruses exploit host cellular proteins and biological
pathways to complete their life cycle. Different influenza virus strains displayed distinct
replication efficiency in different cells, which can be associated with viral entry,
replication, release, and host immune response (155-157). Considering the D/660 and
D/OK IDV strains isolated from cattle and swine respectively, cellular tropism may result
in the distinct replication kinetics. In this regard, four cell lines from different species,
including canine (MDCK), swine (ST), bovine (MDBK) and human (HRT-18G), were
used to compared cellular tropism between D/660 and D/OK virus strains in vitro. Data
in figure 4-1 showed that the D/660 virus replicates more efficiently than the D/OK virus
in all cell lines, indicating that viral factors, not host cellular factors might contribute to
the distinct replication efficiency of IDV.
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Influenza D virus contains seven segments encoding 9 proteins, PB2, PB1, P3, HEF, NP,
M (DM1, DM2), and NS (NS1, NS2). PB2. PB1, P3 and NP together with viral RNA
forms the RNP complex, which serves as a core machinery for replication and
transcription, as well as for transportation and assembly of the genomes into budding
virions (158, 159). In RNP complex, PB1 is an RNA-dependent RNA polymerase (160)
and P3 (named PA in IAV and IBV) is an endonuclease (161, 162). PB2 is essential for
viral transcription by binding the 5′ cap RNA fragment cleaved from host pre-mRNAs
(163). Thus, Natural polymorphisms or genetically engineered mutations targeting
enzyme activities or the interaction of individual RNP complex unit can affect influenza
viral replication efficiency. For example, several amino acid mutations of PB2, including
627K, 591K, 701N, were identified to be responsible for the adaptation of avian H5N1
virus to mammalians (163-165). H5N1 virus containing these mutants increased its
replicative efficiency in mouse model or human cells. Ozawa et al. reported that PB1-F2stop12L mutant exhibited more replication efficiency than wild-type pandemic (H1N1)
2009 influenza virus in MDCK cells (166). As the only major glycoprotein in the surface
of ICV and IDV, HEF contains receptor binding, receptor destroying and membrane
fusion activities (20), determining the virus formation, virion stability and host tropism
(91, 167, 168). M1 protein of influenza virus is an essential component for virion
assembly (169). It is reported that the A24T mutant in M1 protein of ICV changed virus
morphology from a mainly filamentous to spherical appearance. In addition, M1 contains
RNA-binding domains and regulates viral replication by interaction with RNP complex
(170). NS1 was shown to be an inhibitor of interferon innate immune response and
enhance viral replication (171, 172). Moreover, some specific mutants in NS1 are
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associated with virulence and host adaptation (173-175). To investigate which segment(s)
contribute to different grow kinetics between the two virus strains, D/OK RGS was used
to generate chimeric viruses carrying each segment, polymerase or RNP complex of the
D/660 virus. Our data demonstrated that the NP determined the replication difference
between the D/660 and D/OK virus strains.

We further identified two amino acids of NP were critical for IDV replication. NP with
247D or 381E significantly enhanced viral replication capacities in vitro. To date, crystal
structure of IDV NP is available and amino acid differences between the two IDV strains
are noted in Fig 4-3B (144). Similar with other three types of influenza virus, NP of IDV
forms a small oligomer (dimer, trimer or tetramer) and contains some functional domains
for RNA binding, PB2 binding and nucleus transportation (147, 176, 177). We can see
that the residue 247 is buried and closed to the tetramer interface, while the amino acid
381 locates in the surface of body domain but outside of functional sites. However, it is
too difficult to predict the function of the two residues of NP based on their location. A
number of studies reported mutants of influenza virus NP affected viral replication by
targeting RNP activity (148). For instance, residues S165, R416 and E339 of IAV NP
have been identified to be associated with NP oligomerization (146, 147, 178). Mutant
K470R in H5N1 Influenza A Virus NP increases the viral growth in MDCK cells and
virulence in mouse model (179). In this regard, we examined RNP activities of wild type
or recombinant viruses with mutants by the minigenome replication assay. Intriguingly,
both gain of functional mutants in D/OK virus and loss of functional mutants in D/660
virus exhibited no effect on RNP activities. In addition, by alignment NP sequences of
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existing IDV strains, the position 247 and 381 are occupied by E and K only in the NP of
D/swine/Oklahoma/1334/2011 strain, while D and E are present in all other IDV strains.
Further investigation is needed to better understand the underlying mechanism that drive
swine D/OK depart from all other influenza D viruses including D/660 in these two
critical residues of NP protein.
.
In conclusion, our data demonstrated that the D/660 virus had a higher replication
capacity than the D/OK virus in multiple cell lines. We further identified that genetic
variants at the 247 and 381 residues of NP contributed to the distinct viral replication
capacity between the two virus strains. Interestingly, the two residues of NP had no effect
on RNP activities. These findings may provide some novel insights into NP function on
IDV replication.

4.4 Materials and Methods

4.4.1 Cells and viruses

Five cell lines, Madin-Darby canine kidney (MDCK) cells (ATCC), Swine testicle (ST)
cells (ATCC), Madin-Darby bovine kidney (MDBK) cells (ATCC), HRT-18G cells
(ATCC) and Human embryonic kidney HEK-293T cells (ATCC) were used in this study.
All cell lines were cultured and maintained in Dulbecco’s modified Eagle medium
(DMEM; Gibco, Invitrogen, USA) with 10% (vol/vol) fetal bovine serum (FBS; PAA
Laboratories, Dartmouth, MA, USA) and 100 U/ml penicillin-streptomycin (Life
Technologies, Carlsbad, CA, USA) at 37 ° C with 5% CO2. Serum-free DMEM
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supplemented with 1 μg/ml TPCK-trypsin (Sigma‐Aldrich, St Louis) and 100 U/ml
penicillin-streptomycin was used as the infectious medium. Two influenza D virus strains,
D/bovine/Oklahoma/660/2013 (D/660) and D/swine/Oklahoma/1314/2011 (D/OK), were
propagated and titrated by 50% tissue culture infective doses (TCID50)/ml in MDCK
cells at 37°C. Viruses were stored at -80°C until further use.

4.4.2 Antibodies and regents

The rabbit antisera for NP of influenza D virus were prepared in-house. Polyclonal
antibody against eGFP and monoclonal anti-β-actin antibody was purchased from Santa
Cruz Biotechnology and Sigma-Aldrich, respectively. Goat anti-mouse and donkey antirabbit IRDye 680RD secondary antibodies were obtained from Li-cor.

4.4.3 Plasmid construction and reverse genetics

The rescued recombinant influenza D/swine/Oklahoma/1314/2011 (D/OK) virus strain by
reverse genetics system was described in our previous publication (141). Briefly, the dual
promoter vector pHW2000 was used to produce vRNA by human Pol I promoter and the
murine Pol I terminator from one strand and viral mRNA by the CMV promoter and the
BGH poly(A) signal from the opposite strand. The seven pHW2000 plasmids encoding
seven genomic segments (PB2, PB1, P3, HEF, NP, M, and NS) of IDV were cotransfected into cocultured HEK-293T–MDCK cells. Five days later, supernatants were
collected, and the recombinant virus was passaged and titrated by TCID50/ml in MDCK
cells at 37°C. The gain of functional site mutants (S132T, E247D, K381E, A462T) in NP
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of the D/OK virus strain and loss of functional mutants (L74P, T132S, D247E, E381K,
T462A) in NP of the D/660 virus strain were constructed by using wild type D/OK or
D/660 NP as template following the site directed mutagenesis protocol.

4.4.4 Viral replication kinetics assay

MDCK, ST, MDBK or HRT-18G cells were seeded in 12-well plates in the concentration
of 1 × 105 cells/ml. After 14-16 h, cells were washed by phosphate-buffered saline (PBS)
and inoculated with influenza D virus at a multiplicity of infection (MOI) of 0.01. After 1
h incubation, cells were washed with PBS twice, and corresponding infectious medium
was added. Supernatants were collected at the indicated days post-infection and virus
titers were measured by TCID50 assay in MDCK cells.

4.4.5 Minigenome replication assay

The construction of plasmid containing GFP reporter gene was described previously
(141). For the minigenome replication assay, HEK-293T cells seeded in 12-well plates
with a 70-90% confluent were co-transfected plasmids encoding GFP reporter gene and
influenza D/OK polymerase components (PB2, PB1 and P3) with wild type NP or
mutants by PEI transfection reagent. Forty-eight hours later, HEK-293T cells were
collected and fixed by 2% Paraformaldehyde (PFA). The percentage of positive cells
expressing GFP and mean of fluorescence intensity (MFI) were determined by flow
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cytometry (FACS). Cells were lysed and the expression of GFP, NP and β-actin were
measured by Western Blot analysis.

4.4.6 Structural modeling

The model of influenza D virus NP was constructed by Modeler. The NP structure from
D/bovine/France/2986/2012 was chosen as the template (sequence identity: 98%-99%).
The sequences of IDV NP were then aligned using Muscle. The location of 5 residue
differences between the swine D/OK virus and the bovine D660 virus were colored red.

4.4.7 Droplet Digital PCR

MDCK cells were seeded in 12-well plates and infected with bovine D/660 and swine
D/OK virus at an MOI of 0.01. After 0, 8, 16, 24 or 48-h post-infection, cells was lysed
with TRIzol Reagent (Invitrogen, CA, USA) and extracted according to the
manufacturer’s instructions. A high-capacity cDNA reverse transcription kit (Thermo
Fisher Scientific) and Oligo dT (18) primer were used for reverse transcription reactions
following the manufacturer’s protocol. The ddPCR analysis was performed on Bio-Rad
QX200 ddPCR system with the reaction condition following our previous study (180).
Gene-specific primers and probe for IDV NP segment-drived mRNA were used for
determining viral replication. The mRNA levels of NP were normalized to TATA-Box
binding protein (TBP) and presented as viral mRNA copies per 1000 TBP copies.
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4.4.8 Statistical analysis

At least three independent experiments were performed for all data presented in this
study. Results were analyzed by one-way analysis of variance (ANOVA) followed by
Tukey’s multiple-comparison test using GraphPad Prism 5.0 software. Statistically
significant differences are noted in the figures (*, P<0.05; **, P<0.01; ***, P<0.001).
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CHAPTER 5. CONCLUSIONS AND FUTURE DIRECTIONS

Influenza D virus (IDV) utilizes cattle as a primary reservoir. Increased outbreaks in pigs
and serological and genetic evidences of human infection have raised a concern about the
potential of IDV adapting and transmitting to humans. Here, we directly compared IDV’s
stability to that of other influenza types (A, B, and C) following prolonged incubation at
high temperatures or in a low-pH environment. We found that IDV is the most stable
among four types of influenza viruses. Importantly, we demonstrated that the
hemagglutinin-esterase fusion (HEF) protein, which drives the fusion between viral and
host cell membranes, is the primary determinant for the high thermal and acid stability of
IDV. Considering that there is a link between the acid stability of the hemagglutinin
protein of influenza A virus and its cross-species transmission, further investigation of
the mechanism of HEF-directed viral tolerance to high temperature and low pH may offer
novel insights into tissue tropism and cross-species transmission of influenza viruses.

We developed a plasmid-based IDV reverse-genetics system that can generate infectious
viruses with replication kinetics similar to those of wild-type viruses following
transfection of cultured cells. Further characterization demonstrated that viruses rescued
from the described RGS resembled the parental viruses in biological and receptor-binding
properties. We also developed and validated an IDV minireplicon reporter system that
specifically measures viral RNA polymerase activity. In summary, the reverse-genetics
system and minireplicon reporter assay described in this study should be of value in
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identifying viral determinants of replication fitness, cross-species transmissibility and
pathogenicity of the novel influenza D viruses.

IDV has evolved to three genetic lineages: D/OK-lineage, D/660-lineage and D/Japanlineage, according to the sequences of the HEF gene. The D/OK, D/660 and D/Yamagata
are three lineage-representative strains, respectively. The phylogenesis and antigenicity
of IDV strains from different lineages have been well compared and characterized.
However, The underlying mechanisms that attribute to the variability of the biological
characteristics between IDV lineages are not fully understood. Here, we reported a
significantly phenotypic divergence between the D/OK and the D/660 viruses in
replication fitness. We found the D/660 virus replicated to significantly higher titers than
the D/OK virus regardless of the cell types. By using the reverse genetics system, we
generated recombinant chimeric D/OK viruses in that each of its RNA segments was
replaced with its corresponding segment from the D660 virus, and observed that only the
replication fitness of the chimeric swine D/OK virus containing the D660 NP segment
was significantly increased. Finally, we identified two positions 247 and 381 within the
NP protein were key determinants of the replication difference between the D/OK and
D660 viruses. Interestingly, we have observed that theses amino acid changes in the NP
might alter the functionality of NP in the late stage of the replication cycle but not
affected IDV RNP activity in the mini-genome replication studies, which warrants further
investigation. In the present study, we demonstrated that genetic variations of the NP had
a substantial impact on IDV replication fitness. In light of the fact that we have developed
a robust reverse genetics system for influenza D virus as reported in this dissertation, it
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will facilitate future studies towards understanding the cross-species transmission
mechanism at the molecular level, and developing a safe and effective vaccine that can be
used to control and prevent of influenza D virus infection of animals and humans.
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